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ABSTRACT
Biofilms are surface-attached multispecies microbial communities that are embedded 
by their self-produced extracellular polymeric substances. This lifestyle enhances the 
survival of the bacteria and plays a major role in many chronic bacterial infections. 
For instance, periodontitis is initiated by multispecies biofilms. The phases of active 
periodontal tissue destruction and notably increased levels of proinflammatory mediators, 
such as the key inflammatory mediator interleukin (IL)-1β, are typical of the disease. 
The opportunistic periodontal pathogen Aggregatibacter actinomycetemcomitans is 
usually abundant at sites of aggressive periodontitis. Despite potent host immune system 
responses to subgingival invaders, A. actinomycetemcomitans is able to resist clearance 
attempts. Moreover, some strains of A. actinomycetemcomitans can generate genetic 
diversity through natural transformation, which may improve the species’ adjustment to 
the subgingival environment in the long term. 
Some biofilm forming species are known to bind and sense human cytokines. As a 
response to cytokines, bacteria may increase biofilm formation and alter their expression 
of virulence genes. Specific outer membrane receptors for interferon-γ or IL-1β have 
been characterised in two Gram-negative pathogens. Because little is known about 
periodontal pathogens’ ability to sense cytokines, we used A. actinomycetemcomitans 
as a model organism to investigate how the species responds to IL-1β. The main aims of 
this thesis were to explore cytokine binding on single-species A. actinomycetemcomitans 
biofilms and to determine the effects of cytokines on the biofilm formation and 
metabolic activity of the species. Additionally, the cytokine’s putative internalisation and 
interaction with A. actinomycetemcomitans proteins were studied. The possible impact 
of biofilm IL-1β sequestering on the proliferation and apoptosis of gingival keratinocyte 
cells was evaluated in an organotypic mucosa co-culture model. Finally, the role of the 
extramembranous domain of the outer membrane protein HofQ (emHofQ) in DNA 
binding linked to DNA uptake in A. actinomycetemcomitans was examined.
Our main finding revealed that viable A. actinomycetemcomitans biofilms can bind 
and take up the IL-1β produced by gingival cells. At the sites of pathogen-host interaction, 
the proliferation and apoptosis of gingival keratinocytes decreased slightly. Notably, the 
exposure of biofilms to IL-1β caused their metabolic activity to drop, which may be 
linked to the observed interaction of IL-1β with the conserved intracellular proteins DNA 
binding protein HU and the trimeric form of ATP synthase subunit β. A Pasteurellaceae-
specific lipoprotein, which had no previously determined function, was characterised 
as an IL-1β interacting membrane protein that was expressed in the biofilm cultures of 
all tested A. actinomycetemcomitans strains. The use of a subcellular localisation tool 
combined with experimental analyses suggested that the identified lipoprotein, bacterial 
interleukin receptor I (BilRI), may be associated with the outer membrane with a portion 
of the protein oriented towards the external milieu. The results of the emHofQ study 
indicated that emHofQ has both the structural and functional capability to bind DNA. 
This result implies that emHofQ plays a role in DNA assimilation. The results from the 
current study also demonstrate that the Gram-negative oral species appears to sense the 
central proinflammatory mediator IL-1β.
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aa Amino acid 
ABTS 2,2’-Azinobis [3-ethylbenzothiazoline-6-sulfonic acid]-diammonium 
salt
Acp Accessory protein




ATCC American type culture collection
ATP Adenosine triphosphate
BilRI Bacterial interleukin receptor I
cBilRI Cytoplasmic form of BilRI
BLAST Basic Local Alignment Search Tool
bp Base pair
BSA Bovine serum albumin
Caf1 Capsule antigen fraction 1 
Caf1A Capsule antigen fraction 1 assembly
cas CRISPR (see below) associated genes
CD Cluster of differentiation
Cdt Cytolethal distending toxin
CFU Colony forming unit
CHAPS 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate
CRISPR Clustered regularly interspaced short palindromic repeats
CRP  Cyclic AMP receptor protein
CSP Colony-stimulating factor-1
DAB 3,3′-Diaminobenzidine
DAMP Damage-associated molecular pattern
DMEM Dulbecco´s modified Eagle´s medium
DNA Deoxyribonucleic acid
eDNA Extracellular DNA
ssDNA Single strand DNA
DPD 4,5-Dihydroxy-2,3-pentanedione
EDTA Ethylenediaminetetraacetate acid
EGF Epidermal growth factor
ELISA Enzyme-linked immunosorbent assay
EmaA Extracellular-matrix protein adhesin-A
EPS Extracellular polymeric substance
FITC Fluorescein isothiocyanate
Flp Fimbrial low molecular-weight pili
GCF Gingival crevicular fluid
GMC Gingival mucosa co-culture
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HACEK HACEK-group contains Haemophilus influenzae, H. parainfluenzae, 
H. aphrophilus, H. paraphrophilus, Cardiobacterium hominis, 
Eikenella corrodens and Kingella kingae
HeLa Human cervical carcinoma cells
HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid buffered saline
HGEC Human gingival epithelial cell
HGF Human gingival fibroblast
HGK Human gingival keratinocyte
H2O2 Hydrogen peroxide
HRP Horseradish peroxidase
HU Histone-like protein (from E. coli strain U93)
IFN-γ Interferon gamma
Ig Immunoglobulin








LAP Localized aggressive periodontitis
LB Luria-Bertani-medium
Lgt Phosphatidylglycerol/prolipoprotein diacylglycerol tranferase
Lnt Phospholipid/apolipoprotein transacylase
Lol Lipoprotein localication machinery
MAPK Mitogen-activated protein kinase 




MSCRAMM   Microbial surface components recognizing adhesive matrix molecule
MW Molecular weight
NF-kβ Nuclear factor-kappa B 
OD Optical density
OM Outer membrane
Omp Outer membrane protein
OPG Osteoprotegerin
PAMP Pathogen associated molecular pattern
PBS Phosphate-buffered saline
PBMC  Peripheral blood mononuclear cell








RANK Receptor activator of nuclear factor kappa B
RANKL Receptor activator of nuclear factor kappa B-ligand




SDS-PAGE Sodium dodecylsulfate polyacrylamide gel electrophoresis
scFv Single-chain variable antibody fragment
SIGIRR Single immunoglobulin interleukin-1 receptor related
SPII Signal peptidase II
spe Spectinomycin
SSC Side scatter
STI Soybean trypsin inhibitor
tad Tight adherence locus
TdT Terminal deoxytransferase enzyme
TEM Transmission electron microscopy
Tfp Type IV pili
TH Helper T-lymphocyte
TIR Toll/IL-1 receptor
TRIF TIR domain-containing adaptor protein inducing interferon-β
TLR Toll like receptor
TSA Tryptic soy agar
TSB Trypticase soy broth
TSB-YE/Glc TSB supplemented with yeast extract and glucose
TNF-α Tumor necrosis factor-α
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ABBREVIATIONS FOR AMINO ACIDS
A Ala  Alanine
C Cys  Cysteine
D Asp  Aspartic acid
E Glu  Glutamic acid 
G Gly  Glycine
H His  Histidine
I Ile  Isoleucine
K Lys  Lysine
L Leu  Leucine
M Met  Methione
N Asn  Asparagine
P Pro  Proline
Q Gln   Glutamine
R Arg  Arginine
S Ser  Serine
T Thr   Threonine
V Val  Valine
W Trp  Tryptophan
Y Tyr  Tyrosine
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1. INTRODUCTION
Bacterial biofilms are surface attached microbe communities in which microbial cells are 
surrounded by a matrix of extracellular polymeric substances. This biofilm lifestyle is 
hypothesised to be the reason for most bacterial infections [1]. The structural properties 
of complex polymicrobial biofilms and the interaction between the community members 
improve resistance against the host defence system targeted against biofilms (reviewed 
in [2,3]). Moreover, biofilm cells actively monitor their milieu and dynamically adjust 
their properties to the prevailing environment. Therefore, bacteria express particular 
genes only when it is essential. For instance, expression of bacterial virulence genes 
is regulated by sensing changes in the levels of certain compounds, such as bacterial 
signalling molecules, host derived compounds, toxic oxidants and iron (see reviews [4-
6]). Notably, the bacteria living in biofilms have been suggested to exploit cytokines, the 
proinflammatory mediators of the host, to modulate their gene expression and biofilm 
formation [7-9]. Two bacterial cytokine receptors have even been described [8,10]. The 
outer membrane protein of Gram-negative Yersinia pestis, capsule antigen fraction 1 
assembly protein (Caf1A), binds human IL-1β [10]. Another Gram-negative bacterium 
Pseudomonas aeruginosa binds IFN-γ through the outer membrane protein OprF [8]. 
However, the detailed mechanism of bacterial cytokine sensing is still incomplete. 
Moreover, it is unknown whether bacterial cytokine sequestering manipulates host-
cytokine signalling.
Periodontitis is an infectious and inflammatory disease in tooth-supporting tissues, 
and it is associated with subgingival biofilms. The presence of high cytokine levels 
in gingival crevicular fluid is an indication of an active host inflammatory immune 
response during the aggressive form of the disease [11-16]. The host’s own immune 
response against subgingival pathogens mediates periodontal tissue destruction in an 
indirect manner (see reviews [17,18]). This thesis investigated for the first time if an oral 
opportunistic pathogen utilises the host inflammatory marker interleukin-(IL)-1β. The 
ability of a bacterium to disturb host cytokine signalling would partly explain the more 
quiescent phases of the disease. Aggregatibacter actinomycetemcomitans was chosen 
as a model organism for the study as the species is typical of subgingival biofilms in 
aggressive periodontitis [19-22], and its genome sequence is known [23]. IL-1β is a 
key proinflammatory mediator (see reviews [24,25]) that is expressed at high levels in 
periodontal tissue during aggressive periodontitis [12]. This more detailed molecular 
mechanism of pathogen-host crosstalk using cytokines will increase the understanding 
of virulence regulation of pathogens during chronic infections.
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2. LITERATURE REVIEW
2.1. Subgingival species in periodontal health and disease
Hundreds of different bacterial species have chosen to live in the oral habitat. It is 
estimated that each individual may host from 100 to 200 different oral bacteria species 
(see reviews [22,26]), whereas almost 1200 different taxa have been identified in the 
entire human oral microbiome using 16S ribosomal RNA gene sequencing [27]. One 
explanation for the successful colonisation of the oral niche by diverse micro-organisms 
is their ability to live on the tooth as surface attached communities or biofilms.
In general, the biofilm mode of growth within a disease course is estimated to be a 
requisite for over 80% of bacterial infections [1]. These biofilm-based infections are 
typically highly tolerant of the host immune system and antibiotics (reviewed in [2]). For 
instance, periodontitis is a common inflammatory disease in the tooth-supporting tissues 
that is induced by bacterial biofilms. The rotation of short active tissue destruction 
and extended episodes of inactivity is characteristic of periodontal disease [11]. In the 
aggressive forms of the disease, rapid and severe destruction occurs in tooth-supporting 
connective tissue and alveolar bone. Severe periodontitis affects approximately 15-20% 
of adults, and the untreated disease leads to tooth loss among early middle-aged individuals 
[28]. 
Periodontitis is a complex inflammatory disease. Therefore, both disease initiation 
and progression can vary greatly among individuals. Though bacteria are essential 
for periodontitis initiation, host genetic and environmental factors also have a major 
impact on disease severity (reviewed in [29]). According to the “ecological plaque 
hypothesis” by Philip Marsh (see review [30]), a dynamic relationship exists between 
the environment and the composition of the dental biofilm. Formation of the enhanced 
biofilm in the subgingival site launches an active immune response. The response 
targeting the bacteria may cause an alteration in the subgingival milieu that supports 
the outgrowth of periodontal pathogens [30]. Attempts by the host defence system to 
combat the bacteria cause tissue destruction in the periodontal area, while the biofilm 
remains unharmed (reviewed in [31]). Additionally, the genetic and ethnic background 
of the individuals and lifestyle-associated factors, such as smoking [32], can increase 
the risk of periodontal diseases (reviewed in [29]). For instance, it has been suggested 
that individuals with single nucleotide polymorphisms in specific locations in two 
proinflammatory mediators, tumour necrosis factor (TNF) and interleukin (IL)-1A, 
are vulnerable to periodontitis if they are also colonised by the combination of three 
periodontopathogenic species, Tannerella forsythia (formerly Bacteroides forsythus), 
Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans (formerly 
Actinobacillus actinomycetemcomitans) [33]. An imbalance in the cytokine networks 
has been suggested to play a critical role in the progression of periodontitis [34].
Additionally, the microbial profile between periodontal patients fluctuates considerably 
[22,33]. Subgingival biofilms can be comprised of a complex mixture of archaea, 
bacteria, fungi and virus species (reviewed in [35]) that are surrounded by the protective 
extracellular matrix. However, Gram-negative species usually dominate Gram-positive 
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species in periodontal disease. P. gingivalis, T. forsythia, A. actinomycetemcomitans, 
Fusobacterium, Prevotella, Campylobacter and Treponema denticola are Gram-negative 
periodontal pathogens frequently identified from the subgingival plaques of periodontal 
patients using cultivation-based identification techniques [36-38]. Moreover, the use of 
a modern technique, checkerboard DNA-DNA hybridisation, has verified the presence 
of high levels of A. actinomycetemcomitans in the most diseased sites of generalised 
aggressive periodontitis subjects [22]. In addition to bacterial species, the fungus 
Candida albicans [39] and herpesviruses [40] are often isolated from subgingival sites 
of periodontal patients. Due to the complex composition of subgingival flora both in 
healthy and diseased individuals, it is recommended that one also concentrate on the 
functional diversity of bacteria rather than only on the phylogenetic diversity when host-
microbe interactions are investigated (reviewed in [35]). 
The properties of biofilms and thus their ability to cause disease are much more 
than the sum of the properties of the individual cells that form them. Therefore, even 
bacterial species that occur in low abundance may have a significant impact on the entire 
biofilm community composition, diversity and structure [41,42]. The presence of two 
periodontal pathogens, A. actinomycetemcomitans and P. gingivalis, influences the gene 
expression profiles of the nonpathogenic community members in a multispecies biofilm 
model [43]. Additionally, even different isolates of one bacterial species demonstrate 
different levels of virulence. For instance, individuals of African ancestry more often 
accommodate a highly virulent JP strain of A. actinomycetemcomitans [44] that produces 
enhanced amounts of leukotoxin [45,46]. Additionally, this strain has been suggested to 
increase the risk for early onset periodontitis, as the JP2 strain is often isolated from 
young patients with localised aggressive periodontitis (LAP, formerly localised juvenile 
periodontitis) [44,47]. More importantly, recent studies investigating the response of 
gingival cells to periodontopathogens have shown different cytokine production profiles 
after exposure to either planktonic or biofilm forms of oral bacteria [48,49]. Despite this 
result, most of the previous studies investigating the interaction of gingival cells with 
periodontopathogens have been performed with planktonic bacteria.
2.2. The opportunistic oral pathogen Aggregatibacter 
actinomycetemcomitans
A. actinomycetemcomitans is a Gram-negative, nonmotile, facultative anaerobic 
coccobacillus. It is rod-shaped and 0.4–0.5 µm x 1.0–1.5 µm in size [50]. A. 
actinomycetemcomitans exhibits enhanced growth under micro-aerophilic conditions 
[51]. This species is a member of the Pasteurellaceae family, which contains many 
mucosal surface-preferring pathogens of the upper respiratory tract and oral cavity 
[52]. A. actinomycetemcomitans is able to attach firmly to surfaces such as teeth and 
subgingival crevicular epithelial cells [53,54]. In conjunction with other species, A. 
actinomycetemcomitans forms subgingival biofilms [55-58] and colonises moderate 
gingival pockets of 5 to 7 mm in depth [59]. A. actinomycetemcomitans can also invade 
the oral epithelium [60,61] and human gingival fibroblasts [62], enhancing the persistence 
of this pathogen against periodontal treatment.
This opportunistic oral pathogen is included in the periodontopathogens group [20], 
though the species can occasionally be isolated from healthy sites of the periodontium [21], 
14 Literature Review 
and its low occurrence at diseased sites is not unusual [15,22]. However, numerous studies 
have reported the presence of A. actinomycetemcomitans biofilms in diseased sites with 
aggressive tissue destruction [19-21]. Additionally, a recent study supports the role of this 
species in periodontitis by demonstrating that high levels of A. actinomycetemcomitans 
accompanied by Capnocytophaga sputigena were found at sites of advanced aggressive 
periodontitis [22]. In addition to periodontal sites, A. actinomycetemcomitans can exist 
in sites that are very far from an oral cavity, such as in atherosclerotic plaques [63-
65]. A. actinomycetemcomitans is actually linked to atherosclerotic diseases. First, A. 
actinomycetemcomitans belongs to the HACEK group with Haemophilus influenzae, 
H. parainfluenzae, H. aphrophilus, H. paraphrophilus, Cardiobacterium hominis, 
Eikenella corrodens and Kingella kingae. The members of the HACEK group are all 
Gram-negative bacteria known to cause clinical diseases, such as endocarditis. In reality, 
4% of endocarditis may be caused by bacteria belonging to the HACEK group (reviewed 
in [66]). Moreover, high levels of serum immunoglobulin (Ig)-A antibodies against A. 
actinomycetemcomitans [67,68] and salivary A. actinomycetemcomitans are associated 
with coronary artery disease outcomes [68].
A. actinomycetemcomitans can be divided into seven serotypes (a-g) based on the 
different composition of the surface polysaccharides of the species [69-73]. It has 
been suggested that the virulence of the different strains can be serotype-specific 
[21,47,73]. However, it is known that genomic differences might be greater within 
strains of the same serotypes than between strains of different serotypes [74]. In 
fact, the entire genomic sequences of some A. actinomycetemcomitans strains are 
known. For example, the complete genome of the A. actinomycetemcomitans D7S-1 
strain (serotype a) is composed of 2,308,328 nucleotides and 2,432 predicted coding 
sequences [23]. The circular genome of A. actinomycetemcomitans D11S-1 (serotype 
c) is 2,105,764 nucleotides in length and contains 2,134 predicted coding sequences 
[75]. Therefore, different A. actinomycetemcomitans strains may display notable 
genomic diversity both in their genomic content and arrangement [74,76]. Based on 
the genomic data analysis of eleven A. actinomycetemcomitans strains, approximately 
20% or less of the genes of each A. actinomycetemcomitans strain encode flexible 
genes, whereas the rest of the genes belong to the core genome [74]. Knowledge of 
species genetic diversity and exact sequence alterations have explained why some 
strains of this species possess unique pathogenic potential. For instance, the elevated 
leukotoxin expression of the JP2 strain is caused by a specific 530-base pair (bp) 
deletion within the leukotoxin-encoding gene promoter region [46,77]. It is also 
known that the JP2 strain is unable to use human haemoglobin as its iron source, as 
the gene encoding haemoglobin-binding protein A is nonfunctional in the strain. The 
JP2 strain is thus dependent on other mechanisms for the acquisition of this essential 
compound for bacterial growth. [78]
2.2.1. Molecular players of A. actinomycetemcomitans in host-pathogen crosstalk
Toxins and their role in A. actinomycetemcomitans-host interaction
A. actinomycetemcomitans can produce toxins that have a major impact on the viability 
and proliferation of human cells. Leukotoxin interacts specifically with the leukocyte-
specific CD18 antigen subunit of dimeric lymphocyte function-associated antigen-1 
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receptor [79]. Leukotoxin then kills leukocytes, such as polymorphonuclear leukocytes 
[80] and monocytes [81], by forming pores in their cell membranes. Additionally, 
it induces the rapid release of the proinflammatory mediators IL-1β and IL-18 from 
macrophages and monocytes [82,83].
Cytolethal distending toxin (Cdt) produced by A. actinomycetemcomitans has 
been shown to inhibit host cell proliferation by causing apoptosis and cell cycle arrest 
in the G2 phase [84] in several mammalian cell lines, including gingival fibroblasts 
[85,86] and gingival epithelial cells [87]. The ability to produce Cdt, a heterotrimeric 
AB-type genotoxin, is common in several Gram-negative mucocutaneous bacterial 
pathogens. This holotoxin is composed of CdtA, CdtB and CdtC components (reviewed 
in [88]). The CdtB component is the active subunit and functions as DNase [89] and 
phosphatidylinositol 3-phosphate phosphatase [90]. This DNase toxin likely induces 
double strand breaks in the DNA, leading to DNA damage response pathway activation 
in host cells, which eventually causes cell cycle arrest. The delivery of CdtB to host cells 
is dependent on the CdtA and CdtC components of the holotoxin (reviewed in [88]). 
Treatment of Chinese hamster ovary cells with labelled Cdt revealed that CdtB is found 
in the nucleus within 4.5 h after treatment. The labelled CdtC was found on the cell 
surface and in the cytosol, whereas CdtA remained associated with the outer membrane. 
The presence of CdtC in the cytosol suggests that CdtC functions as an accessory protein 
in the delivery of CdtB into host cells [91].
A. actinomycetemcomitans Cdt causes histologically visible damage to the oral 
epithelium [92-94]. A. actinomycetemcomitans Cdt may act by disrupting gingival 
epithelium cell-cell contacts, as Cdt has been shown to affect the allocation and 
expression of adherens junction proteins, including E-cadherin, β-catenin and β-actin, 
in epithelial cells [94]. The structural integrity of the gingival epithelium is essential 
in preventing attempts by the bacteria to enter the underlying connective tissue [94]. 
It has also been hypothesised that defects in the proliferation of epithelial cells and 
periodontal fibroblasts due to Cdt exposure are connected to disturbances in the 
repair of the epithelial barrier and remodelling of the periodontal connective tissue 
(reviewed in [95]). Additionally, Cdt can induce receptor activator of nuclear factor 
kappa B-ligand (RANKL) expression in gingival fibroblasts, periodontal ligament 
cells [96] and Jurkat T-cells [97], thus contributing to bone destruction. Therefore, 
Cdt can be considered a highly potent virulence factor of A. actinomycetemcomitans 
in periodontitis.
Adhesins of A. actinomycetemcomitans interact directly with host surface proteins 
Adhesins are bacterial cell surface components that mediate bacterial adhesion to 
eukaryotic cell surfaces through binding to eukaryotic surface receptors. Adhesion is 
a central event for bacterial colonisation and invasion (reviewed in [98]). Bacterial 
adhesion to host cells involves complex crosstalk with the host cells. For instance, 
Actinobacillus pleuropneumoniae upregulates the expression of an autotransporter 
adhesin during its interaction with lung epithelial cells [99]. A. actinomycetemcomitans 
uses fimbrial appendages when it attaches to host tissues through nonspecific binding 
[55] or non-fimbrial adhesins when it interacts directly with host surface receptors [100]. 
The three central adhesins of A. actinomycetemcomitans and their functions are listed in 
Table 1.
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Table 1. Adhesins of A. actinomycetemcomitans that interact with human extracellular matrix 
components
Name Function/Structural homologues References
Aae - autotransporter adhesin protein (~130 kDa)
- homologue of epithelial cell adhesin (Hap) of H. 





- adhesin that interacts with fibronectin  
(OmpA monomer size of 32 kDa)
- sequence homology with Yersinia enterocolitica adhesin 
YadA 
[100,102,103]
EmaA - extracellular-matrix protein adhesin-A
- homotrimeric adhesin (monomer size of ~200 kDa) that 
binds to collagen (type I, II, III and V) and fibronectin
- member of the oligomeric coiled-coil adhesin family 
of autotransporter adhesins; an orthologue of the Y. 
enterocolitica adhesin YadA
[104-107]
Autotransporter adhesin protein (Aae) was the first characterised A. 
actinomycetemcomitans protein found to be involved in the specific adherence 
of the species to epithelial cells. Deletion of the aae gene from two separate A. 
actinomycetemcomitans strains reduced the mutant strains’ ability to bind to epithelial cells 
compared with wild type (WT) species [54]. Outer membrane protein 100 (Omp100) of A. 
actinomycetemcomitans is also known as surface-expressed A. actinomycetemcomitans 
adhesin. Deletion of the omp100 gene from the A. actinomycetemcomitans Y4 strain 
led to decreased adhesion and invasion efficiency in mutants. Similarly to the omp100 
gene mutation, use of the anti-Omp100 antibody blocks the bacterial adhesin interaction 
with human extracellular matrix components and causes a significant decrease in A. 
actinomycetemcomitans adhesion to human cells [103]. Bacterial adhesin Omp100 
interacts with human extracellular matrix fibronectin, and human gingival epithelial cells 
(HGEC) induce the expression of human beta defensins via the mitogen-activated protein 
kinase (MAPK) pathway as a consequence of this interaction [100]. Moreover, EmaA of 
A. actinomycetemcomitans binds specifically to collagen and fibronectin [104,105]. The 
deletion of this bacterial adhesin reduces the binding of an A. actinomycetemcomitans 
knockout strain to the exposed collagen of rabbit cardiac valve tissue by five-fold in 
comparison with a WT bacterium [106].
A. actinomycetemcomitans may adapt to changing environmental conditions by 
modulating its adhesion properties both at genomic and phenotypic levels; it shows 
differences in the expression of virulence factors related to bacterial adherence and 
colonisation when cultured in microaerophilic or anaerobic conditions [108]. The adhesion 
to epithelial cells is a prerequisite for subsequent bacterial invasion of periodontal tissues. 
A. actinomycetemcomitans can invade epithelial cells and remain viable inside the host 
cells, although little is known about the exact invasion mechanism [60]. On the contrary, 
invasion of the periodontal bacterium P. gingivalis into host cells is a complex process 
involving signal cascades and cytoskeletal rearrangements in host cells (reviewed in 
[109]). One putative explanation for the ability of A. actinomycetemcomitans to survive 
inside eukaryotic cells may be related to the expression of an invasion-associated enzyme 
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encoded by the apaH gene. This enzyme is diadenosine tetraphosphatase, which shows 
sequence homology with characterised bacterial invasion-associated genes such as ygdP 
of E. coli [110]. Interestingly, when cultured under anaerobic conditions, the species 
increased its expression of apaH and emaA genes compared with microaerophilic 
conditions. Similarly, its ability to invade epithelial cells increased under anaerobic 
conditions [108].
2.2.2. Natural competence in A. actinomycetemcomitans
Bacteria are thought to possess complex extracellular DNA (eDNA) uptake systems 
for various purposes, including providing nutrients and nucleic acid precursors, 
acquiring genomic diversity and enhancing their genomic stability [111,112]. Natural 
competence is a transient state in most bacterial species, and its regulation is dependent 
on factors such as the nutritional state and/or quorum sensing (QS) (reviewed in [113]). 
Competence regulation in A. actinomycetemcomitans has been investigated to a lesser 
degree than in its close relative species, H. influenza, which induces the expression of 
several competence-related genes during nutrient starvation or a shortage of nucleic 
acid precursors [114,115]. Competence development in H. influenzae is dependent on 
the expression of competence regulon genes, which are under the control of Sxy and 
cyclic AMP receptor protein (CRP) regulators [116]. Seventeen of the 26 competence 
regulon genes are required for successful natural transformation in H. influenzae [116]. 
Alternatively, competence development in Gram-positive Streptococcus pneumonia is 
mediated by a competence-stimulating peptide-dependent QS system [117]. Evidence 
of QS-dependent competence regulation in Gram-negative bacteria is found only in 
Vibrio cholerae. This species expresses the periplasmic single-stranded DNA (ssDNA) 
binding protein ComEA only at high cell densities, thus regulating DNA uptake in a QS-
dependent manner [118,119]. 
Some A. actinomycetemcomitans strains, such as D7S-1, are naturally competent [120]. 
They import eDNA from the proximal milieu and combine it into their genomes through 
homologous recombination. It has been suggested that A. actinomycetemcomitans can 
use competence as a mechanism for adjusting to changing environmental conditions and 
that noncompetent strains arise when the genomic content of current strains is beneficial 
for the prevailing stable conditions [121]. Based on transformation experiments and 
bioinformatic analyses, competent A. actinomycetemcomitans strains belong to the 
minority [121,122]. In transformation assays, most serotype a strains are able to perform 
DNA uptake, whereas noncompetence is more typical in serotype b and serotype c 
strains [122]. The comparative genomic analysis of A. actinomycetemcomitans strains 
suggests that the genomic variance among species is connected with natural competence 
[121]. The genomes of competent strains appear to be more dynamic compared with 
noncompetent strains; noncompetent strains often contain foreign DNA derived from 
plasmids and phages. Additionally, noncompetent A. actinomycetemcomitans strains 
demonstrate an increased number of deletions or loss of function mutations in genes 
encoding the system responsible for foreign DNA elimination. This loss of the bacterial 
adaptive immune system can be beneficial for minor adjustments, as it allows the intake 
of plasmids and phage DNA [121]. The bacterial adaptive immune system is known 
as the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas immune 
system. Cas proteins are encoded by CRISPR-associated genes (cas). These Cas proteins 
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can play a role in events such as CRISPR RNA processing and target DNA cleaving. 
The first requirement for a functional CRISPR/Cas immune system is the acquisition of 
short fragments of foreign nucleic acids and the integration of these fragments into the 
cognate repetitive loci of the host bacterium chromosome. The expression of a variety of 
diverse CRISPR RNAs in the host leads to complementary base pairing with invading 
foreign DNA, which causes the elimination of foreign DNA, such as DNA from phages 
and plasmids (reviewed in [123]).
2.3. Biofilms
2.3.1. Structural components of biofilms
In biofilms, single bacterial cells are embedded inside the self-produced extracellular 
polymeric substance (EPS) matrix that can comprise up to 90% of biofilm mass (reviewed 
in [124]). Due to the highly hydrated nature of the EPS, it has received nicknames 
such as glycocalyx or slime. However, the overall structure of mature biofilms is 
highly differentiated, and biofilms exhibit heterogeneity at the structural, chemical and 
biological levels. Biofilm matrix is composed of water; carbohydrate polymers, such as 
hexosamine that consists of the linear chains of poly N-acetyl-D-glucosamine residues 
(PGA) in β(1,6) linkage; eDNA; secreted proteins; absorbed nutrients; metabolites; and 
products of cell lysis. EPS plays a significant role in biofilm attachment to surfaces, 
aggregation of single cells and stabilisation of community structure (reviewed in 
[124,125]). Interestingly, the DNA-binding nucleoid-associated proteins IHF and HU 
(integration host factor and histone-like protein from E. coli strain U93, respectively) 
may play a major role in maintaining the integrity of the eDNA content of the EPS 
matrix [126,127]. For instance, H. influenzae biofilms showed destabilisation after 
treatment with anti-IHF antibody, and both DNA-binding proteins were required for 
biofilm formation in E. coli [126].
In vivo biofilms, such as subgingival biofilms, can contain hundreds of different 
bacterial species [26] without considering the virus and yeast species content. These 
different species and even different bacterial strains make their own contributions 
to the general biofilm architecture and especially to EPS consistency. Moreover, 
environmental conditions affect biofilm structure and formation (reviewed in [125]). 
Several environmental factors, such as temperature, nutritional conditions, oxygen 
availability, pH and iron level, may all have effects on the expression of biofilm 
determinants and biofilm formation (reviewed in [128]). The overall architecture of 
biofilms is a mushroom- or tower-like structure with water channels located between the 
pillars formed by microbial cell clusters immobilised in EPS (reviewed in [124,125]). 
The importance of these water channels for biofilm growth has been studied with Gram-
positive Bacillus subtilis. The biofilm growth of this species appears to be dependent on 
the presence of structured water channels that allow efficient transportation of nutrients 
and waste products through the biofilm community [129]. However, little is known about 
the putative liquid transport mechanism and the presence of specific water channels 
inside the biofilms formed by Gram-negative bacteria or periodontal pathogens.
Inside a biofilm, compounds occur in gradients between different layers of the biofilm. 
Therefore, the concentration of essential compounds such as oxygen and nutrients varies. 
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Accordingly, anaerobic and aerobic micro-organisms prefer to inhabit different layers of 
biofilms. There can also be great heterogeneity in the metabolic activity of bacteria, 
as the biofilm may contain very active cells, low activity cells and even metabolically 
dormant persistent cells (reviewed in [130]). Bacteria have naturally developed different 
mechanisms to survive in nutrient scarce environments such as biofilms. For instance, 
slow-growing A. actinomycetemcomitans utilises a low-energy carbon source, lactic 
acid, and inhibits its glucose uptake. In vitro biofilm co-culture studies suggest that A. 
actinomycetemcomitans can avoid competition with fast-growing Streptococcus gordonii 
bacteria by using lactate, a secondary product of the energy-rich carbon metabolisation 
performed by S. gordonii [131]. Moreover, the A. actinomycetemcomitans biofilm 
responds to hydrogen peroxide (H2O2), another metabolite produced by S. gordonii. The 
presence of H2O2 in proximity to the A. actinomycetemcomitans biofilm induces the 
expression of catalase and the serum protein H binding protein ApiA. As result of this 
sensing, the A. actinomycetemcomitans biofilm become more resistant to toxic H2O2 
through the action of catalase, and the biofilm can inhibit serum complement activity by 
binding to serum protein H. [132] The polymicrobial interaction between these two oral 
bacteria thus influences biofilm resistance to innate host immunity.
The structural properties of biofilms increase their resistance to host immune cells, 
antibodies, and various antimicrobials [147,148], (see review [133]). For instance, 
Gram-positive Staphylococcus aureus, which is associated with many surgical site 
infections [134], and Gram-negative periodontopathogen Prevotella intermedia can 
form biofilms resistant to phagocytosis [135]. Human macrophages are incapable of 
phagocytosing biofilm-associated S. aureus, and it has been suggested that this resistance 
is a result of the size and/or physical complexity of the intact biofilm [134]. Additionally, 
periodontopathogen P. intermedia biofilms are resistant to polymorphonuclear leukocytes 
(PMNL), although a strain unable to form biofilms is internalised by PMNLs [135]. 
The exopolysaccharide Pel and eDNA of P. aeruginosa biofilm have been suggested to 
both provide structural support for the biofilm and protect against positively charged 
antimicrobial aminoglycosides by binding these cations [136,137]. 
Interestingly, cells living in biofilms have been shown to more efficiently take up 
and integrate free eDNA than their planktonic counterparts [138-141]. For example, 
the oral Gram-positive bacterium Streptococcus mutans uses a biofilm-specific peptide 
pheromone QS signal transduction system to stimulate the uptake and incorporation of 
foreign DNA [138]. The transformation efficiency rates can be 10- to 600-fold higher 
in biofilms than in planktonic cultures [138]. However, the biofilm cultures of Gram-
negative oral bacteria have not yet been used in transformation efficiency assays. 
Nevertheless, actively growing biofilms of Gram-negative Acinetobacter species are 
competent [142]. Additionally, studies with H. influenzae have shown that defects in the 
operons of the essential competence genes pil and com cause altered biofilm structures 
with reduced biofilm formation as well as the loss of transformability in mutants [143]. 
Particularly, all pil mutants showed significantly decreased biomass compared to the WT 
strain. Moreover, expression of both the pil and com genes was critical for the biogenesis 
and function of type IV pili (Tfp); this expression occurred only at alkaline pH (pH 8.5 
to 9) and was not observed at neutral pH [143,144]. In general, intact Tfp structures are 
required for pilus-pilus interactions and bacterial cell autoaggregation in microcolony 
formation during the early phases of biofilm development (reviewed in [145]). 
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2.3.2. Biofilm lifecycle from single cell attachment to dispersion
The lifecycle of biofilms is a dynamic process composed of different stages that are 
shown in Figure 1. Microbial cells must first attach to human tissues or to abiotic 
surfaces. The colonisation of oral bacteria on surfaces, such as salivary pellicles on 
the teeth or subgingival epithelium, occurs in spatiotemporal order. Some bacterial 
species function as initial colonisers to which the late colonisers adhere [146]. When 
bacteria are attached densely enough to surfaces, they can communicate with each other 
through QS. QS signals control the secretion of EPS, subsequent biofilm maturation and 
detachment. The regulation of bacterial cell death has been suggested to be important for 
biofilm maturation, as the genomic DNA released from lysed cells is a central structural 
component for the developing biofilm matrix [149], (see review [150]). The final stage 
of biofilm formation includes the active release of cells from the biofilms into the 
environment and their colonisation of new surfaces [149](see review [151]).
Figure 1. Schematic presentation of the different stages of the biofilm lifecycle. Biofilm 
formation initiates with the attachment of a single cell to a surface, followed by microcolony 
formation and the embedding of cells by their self-produced EPS. During the last stage, biofilms 
actively disperse cells. Modified picture from McDougald D. et al. 2013 [151].
In A. actinomycetemcomitans, the initial adhesion to abiotic surfaces is dependent on 
proteinaceous fimbriae [152,153], polysaccharides [154] and extracellular DNA [155]. 
The expression of tight adherence (tad) locus genes is required for nonspecific surface 
attachment by A. actinomycetemcomitans [55] and is essential for biofilm formation 
[156]. Fourteen different proteins (Flp1-Flp2-TadV-RcpCAB-TadZABCDEFG) encoded 
by the tad locus form the machinery of A. actinomycetemcomitans fimbriae production 
[55,157]. The fimbriae of A. actinomycetemcomitans are composed of fimbrial low-
molecular-weight pili (flp) components [158], which are secreted through the outer 
membrane across a secretin channel formed by RcpA proteins. The localisation of RcpA 
as a multimeric complex in the outer membrane is dependent on TadD lipoprotein [159]. 
The only gene of the locus that is not required for functional fimbriae expression is flp2 
[157,160]. After 3 hours of contact with porcine lung epithelial cells, the expression of 
rcpA, tadB and biofilm biosynthesis-related genes increased in biofilms formed by the 
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Pasteurellaceae species Actinobacillus pleuropneumoniae [99]. This example implies 
that bacteria can modulate their biofilm properties as result of host-pathogen crosstalk.
In A. actinomycetemcomitans, iron is known to be particularly important in the 
regulation of both biofilm formation and species virulence. The assumption of iron’s 
significance is supported by the fact that genomes of A. actinomycetemcomitans strains 
contain several putative iron uptake genes [161] and that the species can bind human 
proteins containing iron, such as haemin, haemoglobin and lactoferrin [162]. Moreover, 
the regulatory role of iron in A. actinomycetemcomitans biofilm formation is strengthened 
by the finding that iron deficiency increased both the number of colony aggregates and 
the entire biofilm mass [162,163]. Iron supplementation has been shown to reduce the 
transcription of genes required for biofilm development in A. actinomycetemcomitans 
[163]. For instance, the expression of fimbria, EPS proteins and lipopolysaccharide (LPS) 
biosynthesis genes was decreased [163]. This regulation of iron uptake likely occurs 
via the expression of ferric uptake regulator (Fur) and Fur-responsive noncoding small 
RNAs (sRNA) [164,165]. Fur has been shown to be involved in the regulation of gene 
expression of iron uptake-related genes in several Gram-negative and Gram-positive 
species (reviewed in [166]). The overexpression of a single Fur-regulated RNA reduced 
biofilm formation and also reduced the expression of leukotoxin secretion protein D 
in A. actinomycetemcomitans. In the presence of iron, cells express both Fur and Fur-
responsive sRNAs, which most likely act by base pairing with their target mRNA. [165]
A. actinomycetemcomitans regulates its biofilm dispersal actively via the expression of 
dispersin B protein. Dispersin B is an enzyme that degrades the adhesive polysaccharide 
components of the biofilm matrix and causes biofilm dispersion [154,167,168]. Biofilm 
culture studies have shown that A. actinomycetemcomitans biofilms grown in liquid 
culture showed dispersal and satellite colony formation after 3 days of culture [168]. 
To successfully survive in hostile environments, the biofilm lifecycle must be highly 
regulated to enable its formation, renewal and dissemination. Bacteria have thus evolved 
signalling systems to both temporally and spatially synchronise gene expression in 
biofilm communities.
2.3.3. Cell-cell signalling between bacteria 
QS, a complex cell-cell signalling mechanism, is used to adjust biofilm formation, 
virulence factor expression and many other biofilm properties under constantly changing 
conditions. This communication mechanism is density-dependent. Quorum signifies a 
threshold in attached microbe cell density, which is required to initiate the coordinated 
expression of QS-regulated genes. The neighbouring cells in biofilms produce and sense 
small extracellular signalling molecules, such as acyl homoserine lactones (AHLs) 
(see review [169]), furan derivatives (see review [170]) and small peptides [171], to 
synchronise their responses to external signals. However, bacterial crosstalk is not entirely 
universal, as bacteria express diverse signal compounds and their cognate receptors in 
a species-dependent manner. For example, several periodontal pathogens, including 
A. actinomycetemcomitans, are unable to synthesise AHL signals [172] (reviewed in 
[173,174]).
Several Gram-negative and Gram-positive bacteria can encode the LuxS enzyme, 
which acts in the detoxification process of a metabolic intermediate. LuxS converts toxic 
S-adenosylhomocysteine into 4,5-dihydroxy-2,3-pentanedione (DPD) and homocysteine 
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(reviewed in [175]). The synthesised DPD is converted to an autoinducer (AI)-2 species 
by spontaneous rearrangements. The furan-derived AI-2 signal was initially proposed 
to be a universal signal in intra- and interspecies communication among the bacterial 
community [176], but genomic studies have shown that only some species have a LuxPQ 
or Lsr receptor complex for AI-2 [177]. In fact, LuxS is known to regulate virulence 
gene expression in enterohemorrhagic E. coli [178] and several other species, including 
the oral pathogens P. gingivalis [179] and A. actinomycetemcomitans [180]. In E. coli, 
LuxS controls the expression of the two-component QseBC regulatory system, which 
senses the signalling molecule AI-3 [181]. The QseC component is the signal sensor 
kinase, and QseB is the response regulator [182].
A. actinomycetemcomitans can respond to AI-2, and it possesses a QS signalling 
system [183]. Although the signalling system is not required for the growth of planktonic 
bacteria, it appears to be essential for biofilm growth of the species. The periplasmic 
proteins LsrB and RspB are putative receptors for AI-2 and mediate the compound’s 
intake in A. actinomycetemcomitans [184]. The species induces QseBC expression 
after sensing AI-2 [180]. Researchers have started to uncover the significance of QS 
signalling for virulence in the Pasteurellaceae family. For example, the mutation of 
qseC, lsrB or rbsB in A. actinomycetemcomitans resulted in a decrease in the species 
virulence against mice [180]. Furthermore, alveolar bone loss was significantly reduced 
in mice infected with these mutant strains compared with mice infected with WT A. 
actinomycetemcomitans. The biofilm mass was also lower in cultures formed by the 
qseC mutant strain than in WT cultures [180]). In H. influenzae, deletion of the rspB 
gene resulted in the loss of biofilm load in the middle ear of chinchillas [185]. 
2.3.4. DNA uptake mechanism
The route of DNA from the extracellular space to the cytoplasm likely contains the 
following steps: specific signal sequence recognition by a DNA binding receptor, DNA 
pulling through the secretin channel across the outer membrane to the cytoplasmic 
membrane and single-stranded DNA entry into the cytoplasm (reviewed in [113,186]). 
However, many details of DNA transport have yet to be uncovered, though many genes 
have been determined to be essential for the transport. 
The presence of a specific uptake signal sequence (USS) consisting of the 9-bp 
core sequence 5-AAGTGCGGT-3 is required for efficient DNA transformation in 
Pasteurellaceae species including H. influenzae, A. actinomycetemcomitans, Pasteurella 
multocida, Mannheimia succiniciproducens, and Histophilus somni (Haemophilus 
somnus) [120,187-189]. This genus-specific core sequences occurs approximately 
1,760 times in the genome of the A. actinomycetemcomitans HK1651 strain [190]. 
However, the extracellular surface receptor responsible for USS binding has not yet 
been characterised in Pasteurellaceae. More is known about the specific binding event 
in Neisseria species, as the minor pilin ComP protein prefers to interact with Neisseria-
specific USS [191]. However, A. actinomycetemcomitans does not contain homologues 
to pilin ComP according to BLASTP searches.
Translocation of the DNA through the outer membrane is accomplished by the Type 
IV pili secretion system. According to one dominant hypothesis, DNA passes the outer 
membrane by attaching to the tip of a retracting pilus (reviewed in [192]). The genes 
pilABCD encode the components of the Tfp-system of A. actinomycetemcomitans, and 
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these proteins are essential for its transformation [188]. Recently a completely novel 
urpA gene, which encodes uptake-related protein A (UrpA), was found to be essential 
for species competence, though its exact function in DNA uptake is not yet known [193]. 
However, mutational studies have suggested that deletion of urpA leads to increased 
bacterial aggregate formation in A. actinomycetemcomitans broth culture; according to 
bioinformatics analyses, UrpA localises in the cytoplasm [193]. In H. influenzae, the 
proteins encoded by the com operon (comABCDEF) and the four proteins encoded by 
the pil operon are essential for normal Tfp biogenesis and function [143]. The putative 
roles of these Pil proteins in DNA uptake have been revealed by homology analyses 
and functional studies performed with H. influenzae and Neisseria. The hypothesised 
gated channel for DNA uptake by Neisseria is formed by the outer membrane protein 
complex, a dodecameric form of PilQ. Based on cryoelectron microscopy studies, this 
secretin pore was found to have an internal cavity 5.5 nm in diameter [194]. Moreover, 
the inner cavity domains of neisserial PilQ bind both ssDNA and double-stranded 
DNA in a sequence-independent manner [195]. Proteins homologous to PilQ include 
the ComE protein in H. influenzae [144] and HofQ in A. actinomycetemcomitans [23]. 
In H. influenzae, PilA is the major pilin subunit [143]. PilB protein shows homology to 
hexameric type II secretion and Tfp assembly adenosine 5’-triphosphatases [144]. PilD 
has homology to prepilin peptidases [144], which are responsible for processing prepilin 
molecules prior to pili assembly into filaments [196], and PilC has been linked to the 
regulation of pilus retraction [197]. The DNA transport through the outer membrane 
appears to be adenosine 5’-triphosphate (ATP)-dependent because the use of ATPase 
inhibitors or proton motive-force distributors quenched transport in Gram-negative 
Helicobacter pylori [198].
Translocation of DNA through the cytoplasmic membrane is the second step in 
the DNA uptake process. The process begins when the transforming DNA binds to 
soluble ComE1 protein located in periplasmic space [199,200]. The binding of ComE1 
to incoming DNA has been suggested to exert a force on the DNA, which drives the 
transfer of ssDNA into the cytoplasm [192]. The enzymes responsible for the conversion 
of DNA to the single-stranded form have not been described in vivo, but it is known 
that the other strand of DNA must be degraded from the 5´ end before the resulting 
ssDNA is internalised in the 3´-5´direction across the cytoplasmic membrane [201]. 
The transportation of ssDNA into the cytoplasm occurs across the integral cytoplasmic 
membrane channel known as ComA in Neisseria [202] and as the DNA internalisation-
related competence protein ComEC/Rec2 in A. actinomycetemcomitans. This inner 
membrane channel is highly conserved among competitive bacteria (reviewed in 
[192]). Inside the cell, the binding of DNA processing protein A to ssDNA protects 
the molecule against the degradation caused by cellular nucleases [203] and facilitates 
homologous recombination by the chromosomal recombinase RecA [204]. Successful 
transformation is also dependent on the ComM protein, which is required for DNA 
integration into the genome in H. influenzae [205]. The predicted model of DNA 
uptake of A. actinomycetemcomitans is summarised in Figure 2, and the different 
protein components of the DNA uptake machinery of N. meningitidis, H. influenzae 
and A. actinomycetemcomitans are described in Table 2.
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Figure 2. Model of DNA uptake in A. actinomycetemcomitans. Pil proteins (PilB, PilC and 
PilD) mediate the assembly of the pseudopilus. PilB is the cytoplasmic assembly ATPase, PilC 
is the integral inner membrane protein of the pilus assembly complex, and PilD is the peptidase 
required for prepilin processing. The pseudopilus formed by the assembly complex transvers the 
outer membrane pore formed by the multimeric HofQ. This DNA uptake machinery binds and 
specifically takes up DNA containing the USS. Retraction of the pseudopilus and the putative 
force exerted on the DNA by periplasmic ComEA leads to DNA transfer into the periplasm. The 
subsequent transfer of ssDNA across the inner membrane ComEC/Rec2 channel and its binding 
by protective proteins are the last steps prior to homologous recombination. Figure modified from 
Krüger and Stingl 2011 [192].
 Literature Review 25
26 Literature Review 
2.4. Cytokines
2.4.1. Pathogen recognition leads to cytokine production
The innate host immune system provides the first line of defence against pathogens by 
eliminating pathogens and controlling the launch of a more specific adaptive immune 
response. A key step in this defence strategy is discrimination between pathogens and 
commensals before the initiation of a response. Activation of the inflammatory response 
is regulated by several protective effectors, as unnecessary inflammation can cause 
severe damage to host tissues (reviewed in [209]). When these regulatory blocks have 
been bypassed, pathogen elimination is mediated by phagocytes, including macrophages, 
neutrophils and dendritic cells. Inflammatory mediators, such as IL-1β, are conductors 
of complex immune responses.
To recognise pathogens, host cells encode divergent pattern recognition receptors 
(PRRs), which can recognise the conserved molecular features of the microorganism. 
Some classes of PRRs are membrane-attached receptors, such as Toll-like receptors 
(TLRs), which recognise pathogen-associated molecular patterns (PAMPs) in 
extracellular space or inside subcellular compartments, including endosomes and 
the cytosol. Some cytosolic PRRs can also recognise endogenous damage-associated 
molecular patterns (DAMPs) released by dying or damaged cells (reviewed in [210-
212]). The binding of bacterial products such as lipopolysaccharides to their respective 
PRRs often trigger an innate immune response through the myeloid differentiation 
primary-response gene 88 (MyD88)-dependent pathway (see review [210] and Fig 
3). This pathway involves nuclear factor (NF)-kB-dependent transcription of pro-IL-
1β [210]. Moreover, in the case of TLR3 or TLR4, the binding of pathogen-derived 
components can lead to activation of the Toll/IL-1 receptor (TIR) domain-containing 
adaptor protein inducing interferon-β (TRIF)-dependent pathway (see review [210] 
and Fig 3). The activation of this pathway culminates in the expression of interferon 
(IFN)-α and -β [210,213]. 
In the gingival sulcus, the epithelial cells of the junctional epithelium are the first 
line of defence against bacteria. This mechanical epithelial barrier also acts as a sensor 
of microbial infection, as it contains microbe-recognising PRRs. The recognition of 
pathogens induces cytokine production in epithelial cells following inflammasome 
activation [214,215]. These cytokines are then employed in defence to recruit 
and activate immune cell populations at the site of infection. For example, human 
TLR2 and TLR4 mediate the recognition of exogenous ligands such as lipoproteins 
and lipopolysaccharides from Gram-negative bacteria. TLR2 and TLR4 have been 
suggested to play a role in controlling A. actinomycetemcomitans infection [216,217]. 
Knocking out these genes in mice caused a significant reduction in the production of 
TNF-α and interleukin IL-1β in both mutants. Alveolar bone loss was reduced in TLR4 
mutants [217], whereas TLR2-deficient mice developed more severe bone loss after 
A. actinomycetemcomitans infection [216]. The TLR4-deficient mice also possessed a 
higher bacterial load in the periodontal tissues compared to WT infected mice [217]. 
Moreover, a polymorphism in the human TLR4 gene is associated with periodontal 
disease susceptibility. The missense mutation Asp299Gly in the TLR4 gene has been 
found to be a genetic risk factor for susceptibility to chronic periodontitis. In contrast, 
the missense mutation Thr299Ileu has been found to reduce the risk of aggressive 
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periodontitis [218]. Interestingly, HGECs deficient in TLR4 do not produce IL-1β 
after infection with P. gingivalis or A. actinomycetemcomitans in cell culture studies. 
Furthermore, the nonfunctionality of TLR4 appears to hinder the release of other 
proinflammatory cytokines (IL-6, IL-8, TNF-α) from HGECs after bacterial challenge, 
whereas WT HGECs release these cytokines [214]. Therefore, genetic variations in 
human PRRs can significantly influence the inflammatory response of the host against 
bacteria and the resulting onset of periodontitis.
2.4.2. Interleukin (IL)-1β synthesis, cleavage and secretion
The key immune response modulator IL-1β is mainly produced by monocytes [219] 
and macrophages (see reviews [24,212]); however, it can be produced by other 
cell lines such as gingival fibroblasts [220] and gingival epithelial cells [215]. This 
cytokine is synthesised as a 31-kDa precursor and is cleaved to its 17-kDa mature 
form by caspase-1 of cellular inflammasomes. These cytosolic inflammasomes 
are multi-protein complexes that act as a scaffold, which is required for caspase-1 
activation. They are composed of the “adaptor” protein (ASC, apoptosis-associated 
speck-like protein containing the required C-terminal caspase domain), the “effector” 
protein (caspase-1) and the “sensor” protein (NLR protein, nucleotide binding and 
oligomerisation domain-like receptor, in NLR inflammasomes). The activation of 
PRRs as a response to PAMPs or DAMPs culminates with inflammasome activation 
and proteolytic cleavage of pro-IL-1β into its active form (reviewed in [212,221]). 
However, the regulation of IL-1β production is not identical in monocytes and 
macrophages. Circulating monocytes possess continuously active caspase-1, and they 
can thus release IL-1β after TLRs interact with pathogen-associated molecules. In 
contrast, macrophages require two stimuli before IL-1β is secreted. Binding of the 
ligand to its cognate TLR induces mRNA transcription from the IL-1β-encoding gene, 
but a second alarm of ATP released from lysing cells is required for IL-1β secretion 
[222]. Inflammasome activation as a consequence of ATP  release is linked to a 
change in the ionic environment of the cell. Extracellular ATP activates the P2X7 cell 
membrane receptor, resulting in the opening of the cation-selective ion channel of 
P2X7 (see reviews [223,224]). Mature IL-1β lacks a typical signalling peptide targeting 
it for secretion by the endoplasmic reticulum and Golgi complex and is thus secreted 
unconventionally (see reviews [225,226]). The role of inflammasomes in active IL-1β 
production is described in Figure 3.
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Figure 3. The recognition of PAMPs culminates in the immune response, including cytokine 
and interferon production through a complex signalling pathway. An exogenous ligand such 
as A. actinomycetemcomitans lipopolysaccharide (LPS) interacts with human Toll-like receptor 
(TLR)4 and causes an intracellular signalling cascade. First, the cytoplasmic Toll/IL-1 receptor 
(TIR) domains (purple) of TLR4 recruit two intracellular adaptor proteins TIRAP and Myd88 
prior to the sequential phosphorylation of intracellular kinases. Activation of this Myd88-
dependent signalling pathway then activates NF-κβ transcription factor and initiates cytokine 
expression in the nucleus. However, ligand binding to TLR4 can also lead to recruitment of the 
adaptor protein TRAM, which regulates the TRIF-dependent pathway. Activation of the TRIF 
pathway results in the phosphorylation of IRF3 and IRF7 transcription factors and subsequent 
interferon gene expression (see review [213]). Moreover, active caspase-1 is required to modify 
the translated pro-IL-1β to its mature form. In macrophages, the activation of the caspase-1 is 
controlled by cellular inflammasome complexes, such as NLRP3. When human cells are lysed 
during pathogen infection they release ATP, which is sensed by the neighbouring cells as an 
extracellular alarm signal. Opening of the P2X7 cation channels in the membrane is controlled 
by ATP. It has been suggested that the opening of this channel leads to fluctuation in the 
intracellular cation levels following formation of the active inflammasome complex (reviewed 
in [211,227,228]). Figure adapted from figures from Kondo et al. 2012 [227] and McIsaac et 
al. 2012 [213].
In response to A. actinomycetemcomitans infection, whole blood cells can enhance 
the release of IL-1β and TNF-α after being treated with free soluble surface material 
originating from viable A. actinomycetemcomitans (strain D7S) biofilm or planktonic 
cells of the species. At the transcriptional level, A. actinomycetemcomitans-derived 
material causes a multifold increase in the transcription of proinflammatory cytokines 
(IL-1β, TNF-α, IL-6, IL-8, and macrophage inflammatory protein-1β) in human whole 
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blood cells [229]. It was recently observed that human mononuclear leukocytes increase 
the expression of NLRP3 but reduce NLRP6 inflammasome expression when infected 
with the A. actinomycetemcomitans D7SS strain [230]. The secretion of IL-1β from 
mononuclear cells was enhanced two-fold from baseline during a 3-h challenge with A. 
actinomycetemcomitans [230]. 
2.4.3. IL-1β function
IL-1α and β are well known cytokines that demonstrate multiple and extensive effects on 
nearly every type of human cell. In particular, the role of IL-1β as a significant gatekeeper 
of inflammation has been established. The increased production of this cytokine may 
partly explain the development of variety of diseases, such as atherosclerosis and 
some autoimmune disorders (see reviews [24,25]). The potent IL-1β regulates both its 
own secretion and the secretion of other cytokines from neighbouring cells to adjust 
the host defence against invaders. In addition to its inflammatory role, IL-1β is also an 
influential mediator of human cell differentiation, proliferation and apoptosis [231,232]. 
During pathogen infection, IL-1β influences the release of other major proinflammatory 
cytokines such as IL-6 and IL-8 [214] from human epithelial cells infected with P. 
gingivalis. C. albicans or S. aureus infections induce the differentiation of naive T 
cells into IFN-γ- and IL-10-producing TH17 cell subsets under the regulation of IL-1β 
[233]. Additionally, disturbances in IL-1β levels can indirectly contribute to host tissue 
damage and bone resorption during periodontitis [234-236]. The ability of IL-1β, IL-
6, IL-11, TNF-α and IL-17 to regulate and increase the expression ratio of RANKL to 
osteoprotegerin (OPG) is well described (reviewed in [236]). During inflammation, the 
level of OPG is therefore low compared with the level of RANKL. RANKL can then 
freely interact with the RANK receptor located on the osteoclast precursor surface. This 
RANK-RANKL interaction leads to increased osteoclastogenesis and degradation of the 
alveolar bone. However, OPG binding to RANKL inhibits it binding to RANK, which 
reduces the bone loss caused by RANK-RANKL binding. Osteoblast cells, T and B 
lymphocytes and fibroblasts all express RANKL [236]. The Macaca fascicularis primate 
model of experimental periodontitis suggests that osteoclast formation and periodontal 
bone loss can be reduced 67% and 60%, respectively, with the use of IL-1 and TNF 
antagonists [237].
Activation of the inflammatory signalling cascade is initiated by the interaction of 
extracellular IL-1β with IL-1 receptor type I (IL-1RI) located on the cellular surface. 
IL-1RI is composed of an extracellular immunoglobulin domain and a Toll/IL-1 receptor 
(TIR) domain on the cytoplasmic side. The binding of IL-1β to IL-1RI allows the 
formation of a heterotrimeric receptor complex of IL-1β, IL-1RI and a TIR domain-
containing accessory protein (IL-1RAcP). The MyD88 adaptor protein is then recruited 
to the TIR domain following phosphorylation of the receptor-associated kinases. The 
signal transduction induces NF-κΒ activation, which translocates into the nucleus where 
it induces the expression of inflammatory genes (see Fig 4 and reviews [224,238,239]). 
Due to the various consequences of IL-1β production, it is essential to regulate 
IL-1β function at the gene expression, protein synthesis, propeptide maturation and 
secretion levels. The rate-limiting step of IL-1β production is the transcription of IL-
1β (see review [25]). In IL-1β production, the transcriptional response controls pro-
IL-1β synthesis, and caspase-1 modifies pro-IL-1β as previously described. To expand 
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the control of IL-1β activity even further, human cells express a specific receptor 
antagonist and a decoy receptor known as IL-1Ra and IL-1RII, respectively. The 
secreted IL-1Ra competes with IL-1β for IL-1RI binding. However, IL-1Ra binding 
to IL-1RI does not lead to intracellular signal transduction because the IL-1Ra/IL-
1RI complex is unable to recruit the IL-1RAcP required for signalling (reviewed in 
[224,238,239]). Studies with mice have shown the importance of the correct balance 
between IL-1Ra and IL-1 for the animal’s health. Mice deficient in the gene for IL-
1Ra developed a disease that resembles rheumatoid arthritis and arteritis in humans 
[240]. 
Membrane-associated IL-1RII competes with IL-1RI to bind IL-1β, which thus 
blocks cytokine binding to the functional receptor (see reviews [224,238,239]). The 
cytoplasmic domain of IL-RII is short and does not contain a similar TIR domain 
as in IL-1RI. Due to this structural difference, IL-1β binding to IL-1RII does not 
activate the signalling cascade [241]. However, IL-1RII interacts with IL-1RAcP and 
sequesters free IL-1RAcP from IL-1RI [242]. The disruption of IL-1β homeostasis 
has severe consequences in humans, including autoinflammatory diseases, and IL-
1β blockers, such as IL-1Ra, anti-IL-1, or anti-IL-1-RI antibodies, can be used to 
treat some of these resulting diseases (see reviews [24,25,226]). Many cell types, 
including epithelial cells and leukocytes, can express the Toll/IL-1 like receptor 8 
(TIR8)/single immunoglobulin interleukin-1 receptor-related (SIGIRR) molecule, 
which belongs to the family of interleukin-1R-like receptors like IL-RII. TIR8/
SIGIRR is recognised as a key regulator of inflammation because it can inhibit IL-1RI 
signalling, TLR signalling and NF-κβ activation. TIR8 expression has been suggested 
to disrupt the interaction of IL-1RI with IL-1RAcPs and thus inhibit the activation 
of NF-κB (reviewed in [243]). Understanding of the role of TIR8 in inflammation 
regulation has increased in recent years. For example, the overexpression of TIR8 
in intestinal epithelial cells is known to diminish NF-κβ-mediated IL-8 responses to 
enteropathogenic E. coli or LPS compared to control cells. In contrast, silencing of the 
gene encoding TIR8 resulted in an exaggerated IL-8 response after cell stimulation 
with bacterial flagellin or proinflammatory IL-1β compared with nonsilenced TIR8 
control cells [244]. Moreover, Tir8 knockout mice (Tir8−/−) possesses significantly 
higher lung bacterial loads. Compared to WT control mice (Tir8+/+), these mutant mice 
also demonstrate increased mortality and increased production of proinflammatory 
cytokines (IFN-γ, TNF-α, IL-1β, and IL-6) in lung tissues after an acute P. aeruginosa 
lung infection [245]. Figure 4 shows a schematic presentation of IL-1β signalling and 
signalling inhibition by negative regulators. Table 3 summarises the different types of 
human cells that express IL-1RI, IL-1RII, IL-1Ra and TIR8/SIGIRR.
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Figure 4. The IL-1β signalling mechanism and its inhibition through IL-1RI. Briefly, IL-1β 
binding to IL-1 receptor type I (RI) and the subsequent recruitment of the accessory protein of 
the receptor (IL-1RAcP) to the complex initiates signalling via the phosphorylation of receptor-
associated TIR kinases. After phosphorylation, the cytoplasmic MyD88 adaptor protein is 
recruited. Intracellular signal transduction includes the phosphorylation of IRAKs and IKKβ, 
which leads to activation of the NF-κΒ transcription factor. The activated NF-κΒ enters the 
nucleus and induces the expression of inflammatory genes (reviewed in [224,239,246]). Cells 
also express IL-1RII, which binds IL-1β on the cell surface without causing a signalling cascade. 
Additionally, IL-1R antagonist (IL-1Ra) can interact with IL-1RI and thus block IL-1β binding. 
The negative regulator receptor of ILR and TLR signalling TIR8/SIGIRR dampens intracellular 
signalling pathways (reviewed in [224] and [243]). Figure modified from Dinarello 2011 [224].
Table 3. Human cell types expressing the IL-1 receptors IL-1RI, IL-1RII, and IL-1Ra and the 
IL-1 receptor-like TIR8/SIGIRR receptor.
IL-1 receptors Cell types expressing the IL-1 receptor
IL-1RI - almost all cell types (reviewed in [25])
IL-1RII - mainly macrophages and B cells but also monocytes and neutrophils 
(reviewed in [247, 248])
- soluble form of the receptor is released by B cells [249], peripheral blood 
mononuclear cells [250] and polymorphonuclear cells [251]
IL-1Ra - macrophages/monocytes, blood polymorphonuclear cells/stimulated neutrophils 
[252, 253] and hepatocytes [254], and mesenchymal stem cells [255]
- intracellular IL-1Ra is constitutively produced by epithelial cells in the 
skin and the gastro-intestinal tract [256]
TIR8/SIGIRR
(TIR8)
- expressed by NK cells, B cells, monocytes, immature myeloid dendritic 
cells and intestinal epithelial cells 
- high expression levels detected in tissues of the digestive tract, kidney, liver, 
lung and lymphoid organs (reviewed in [257])
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2.4.4. IL-1β and other cytokines in the periodontal environment
In periodontitis, tooth-supporting tissues and alveolar bone are destroyed as a result of 
inflammation. Figure 5 summarises some major differences in diseased periodontal tissue 
compared with healthy tissue. According to the definition of periodontitis, the depth of 
the gingival sulcus increases from ≤3 mm in healthy subjects to ≥5 mm in patients with 
the disease. Additionally, patients with periodontitis show bleeding when probing the 
pockets. The main characteristics of LAP, as opposed to chronic periodontitis, include 
rapid bone loss and disease breakthrough during early adulthood (reviewed in [17,18]). 
Tissues in the ongoing disease state also show increased local levels of IL-1β in gingival 
crevicular fluid (GCF) compared with healthy sites. Twenty years ago, it was determined 
that tissue biopsies taken from deep sites in gingival pockets (depth of 8.5±0.4 mm) 
contained approximately 4.5-fold higher amounts of IL-1β versus shallow, healthy 
pockets (depth of 2.8±0.3 mm) [12]. Since then several studies have verified that the 
levels of IL-1β increase in GCF taken from deep pocket sites [13-16,258]. Samples taken 
from patients diagnosed with generalised aggressive periodontitis contained the highest 
levels of IL-1β compared with periodontally healthy subjects or patients with chronic 
periodontitis [259]. In addition to increased tissue and GCF levels, IL-1β concentrations 
can also be significantly higher in the saliva of periodontal patients compared with 
healthy control patients [260]. Table 4 summarises the IL-1β concentrations (ng/ml) 
determined from periodontal tissue and GCF.
Table 4. IL-1β levels in periodontal tissue, GCF and saliva. 
IL-1β levels in periodontal tissues (ng/ml)
Healthy sites Active tissue destruction References
6.2±4.6 28.4±7.2 [12]
IL-1β levels in GCF (ng/ml)
Healthy sites Active tissue destruction References
44.8±15.0 86.4±22.0 [13]
147.8±24.6 206.0±20.4 [258]
IL-1β levels in saliva* (ng/ml)
Periodontally healthy Periodontal disease References
0.5±0.3 0.7±0.3 [260]
*The coincident presence of 3 to 5 different periodontal pathogens (A. actinomycetemcomitans, 
P. gingivalis, P. intermedia, T. forsythia, and/or T. denticola) in saliva was demonstrated. 
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Figure 5. The differences in healthy and diseased periodontal sites. The healthy dentogingival 
junction and the same junction during periodontitis are described on the left and right sides of the 
figure, respectively. In periodontitis, a subgingival pocket has formed between the tooth and gum, 
and bacteria have colonised the pocket. Moreover, the flow of gingival crevicular fluid (GCF) is 
enhanced at the infected site, and changes in the pH lead to a more alkaline subgingival environment 
that is typical during periodontitis. Additionally, the amount and composition of the subgingival 
biofilm may change dramatically when the disease develops. As a result of immune response 
activation, the cytokine levels and the osteoclast activator factor (RANKL)/osteoprotegerin (OPG) 
ratio rise at the diseased sites. The complex host response against pathogenic invaders together 
with microbe-derived toxins or proteolytic compounds leads to degradation of the epithelial barrier, 
connective tissue and bone. Despite the aggressive host defence, biofilms may remain viable, and 
some single pathogens may invade periodontal tissue. MMP: matrix metalloproteinase; TLR: Toll-
like receptor. Figure modified from Pöllänen et al. 2012 [262].
2.4.5. Role of IL-6, IL-8, IFN-γ and TNF-α in periodontitis
Some studies have reported significantly higher levels of the co-occurrence of secondary 
cytokines IL-6 and IL-8 with severe forms of periodontal disease [13,264-266]. IL-6 is 
produced by several types of human cells, including gingival fibroblasts [267], gingival 
epithelial cells [268] and monocytes [269] as a 21 to 30 kDa phosphorylated and 
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variably glycosylated molecule [270]. This cytokine has a central role in the regulation 
of B- and T-cell differentiation and growth [271-275]. Therefore, IL-6 knockout mice 
have a compromised response to viral and bacterial infections [276]. IL-8 (<9 kDa), 
a member of the CXC chemokine family, mediates the chemotaxis and activation of 
neutrophils and other immune cells at the inflammation site. IL-8 is secreted by several 
cells in gingival crevice, including monocytes [269], macrophages [277], gingival 
epithelial cells [277,278] and gingival fibroblasts [267]. In vitro studies have shown 
that A. actinomycetemcomitans infection induces IL-8 expression and release in gingival 
cells [268,278] and polymorphonuclear leukocytes [279]. Notably, IL-1β stimulates the 
production of IL-6 and IL-8 from human gingival cells, and the inhibition of IL-1RI 
reduces the production of these cytokines [214,280]. Additionally, TNF-α enhances the 
secretion of IL-6 in gingival fibroblasts [280].
One major cytokine that controls the inflammatory response is TNF-α. This cytokine 
(a monomer of 17.5 kDa) is mainly secreted by macrophages and monocytes, although 
gingival fibroblasts and epithelial cells are also known to secrete it after bacterial 
infection [267,277,279]. Interestingly, TNF-α plays an analogous role in alveolar 
bone destruction to IL-1β [235], and TNF-α levels in GCF are higher in patients with 
generalised aggressive periodontitis compared with healthy subjects or patients with 
chronic periodontitis [259]. Moreover, both IL-1β and TNF-α can induce the expression 
of matrix metalloproteinases, which can degrade the periodontal connective tissue 
(see review [281]). In addition to the abovementioned cytokines, a role for IFN-γ in 
periodontitis development has been suggested. The increased levels of IFN-γ in GCF 
appear to correlate with the diseased periodontal sites in chronic periodontitis [282]. 
However, the levels of IFN-γ in GCF do not increase as much as the interleukin levels 
(IL-1β, IL-6 and IL-8) [15]. IFN-γ is mainly produced by T lymphocytes, but nearly 
all cells except erythrocytes express the IFN-γ receptor (see review [283]). It has been 
suggested that this interferon affects macrophage activation, and IFN-γ is essential in 
the host defence against intracellular pathogens, such as fungi, viruses, and intracellular 
bacteria [284,285]. Interestingly, the absence of IFN-γ in a mouse model infected with 
the A. actinomycetemcomitans JP2 strain caused the bacterial load to increase and 
eventually led to the death of the mice [286]. 
2.4.6. Ability of bacteria to sense host cytokines
IL-1β 
Porat et al. [287] were the first to suggest that virulent E. coli strains can bind human 
IL-1β, and, as a result of IL-1β binding, these virulent strains enhance their growth. 
By using a competitive radiolabeled [125I]-IL-1 binding assay, they showed that IL-1β 
binds to E. coli cells and that this binding could be inhibited using competitive IL-Ra. 
Growth enhancement was observed with final IL-1β concentrations of 10-100 ng/ml. 
Interestingly, the growth promoting effect appeared to be specific for IL-1β, as treatment 
with IL-4 or TNF-α did not have any impact on the growth of virulent or avirulent strains 
[287].
The effect of IL-1β on the growth of other bacterial species was later shown using 
fresh isolates of S. aureus (Gram-positive), P. aeruginosa (Gram-negative), and 
Acinetobacter spp. (Gram-negative). All these species showed concentration-dependent 
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growth enhancement when the bacteria were treated with IL-1β, IL-6 or TNF-α at final 
concentrations of 0.5-10 ng/ml. However, growth enhancement was lost if the bacteria 
were passaged more than five times or if IL-1β treatment was performed in the presence 
of a cytokine neutralising monoclonal antibody [288]. 
The interaction between biofilm-forming bacteria and IL-1β has been best described 
with S. aureus. The findings of these studies strongly suggest that this opportunistic 
pathogen can sense host-derived IL-1β. First, it has been shown that S. aureus biofilm 
cultures are more sensitive to IL-1β (0.1-10 ng/ml) than planktonic cultures. IL-1β 
exposure caused a 2.5-fold increase in the amount of biofilm cells compared to untreated 
cells, but a similar IL-1β growth dependence was not observed with planktonic cultures. 
Second, biofilm cells bound more than five-fold greater amounts of IL-1β than planktonic 
cells according to a flow cytometry assay [9]. It seems that the entire 17.4-kDa mature 
IL-1β protein with an isoelectric point (pI) of 5.9 is not needed for growth enhancement, 
as the phenomenon has also been observed with two linear IL-1β peptide fragments 
(<5 kDa) spanning amino acid (aa) regions 118–147 and 208–240 [7]. Table 5 presents 
the known effects of different IL-1β fragments on S. aureus biofilm or human cells. 
Moreover, Table 5 includes the calculated pI values and molecular weights of the IL-1β 
fragments.







pI* Effect on 
S. aureus biofilm [7]
Effect on human cells/reference
118-147 3.4 9.3 - Growth-
enhancement 
- No biological activity in human 
glioblastoma cells. 
[289] 
148-177 3.3 3.8 - No growth-
enhancement 
- No biological activity in human 
glioblastoma cells. 
[289] 
163-171 1.0 4.1 - Not studied - Immunostimulatory and adjuvant 
effects without inflammatory and 
toxic effects
[290,291]
178-207 3.5 6.2 - No growth-
enhancement 
- No biological activity in human 
glioblastoma cells. 
[289] 
208-240 4.1 9.6 - Growth-
enhancement 
- IL-1β agonist with biological 
activity in human glioblastoma 
cells. 
- Induces intercellular adhesion 
molecule-1 expression, which 
can be blocked by IL-1Ra 
in human glioblastoma and 
neuroblastoma cells 
[289] 
241-269 3.1 4.0 - No growth-
enhancement 
- No biological activity in human 
glioblastoma cells. 
[289] 
*Theoretical molecular weight and pI value for human IL-1β peptide fragments were determined 
by ProtParam analysis [292]. Mature IL-1β spans aa 117-269 of the preprotein.
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Most importantly, IL-1β is known to affect the gene expression of S. aureus. It has 
been shown to modulate the gene expression of toxin-encoding genes and some genes 
responsible for host tissue attachment. For example, high IL-1β levels (25 ng/ml) lead 
to a significant decrease in the expression of four bicomponent leukotoxin-encoding 
genes. In contrast, the expression of these genes increased at low IL-1β levels (5 mg/
ml). However, the gene expression of fibronectin-binding protein and collagen-binding 
protein increased in the presence of high or low IL-1β levels compared with control 
cultures. [293] Kanangat and co-workers [293] have suggested that S. aureus may use 
IL-1β as a cue to change its virulence properties to better meet the requirements for 
battle between the pathogen and host defence systems.
In an organotypic model of nasal epithelium, both IL-1α and IL-1β inhibited the 
growth of a nasal carrier strain of S. aureus [294]. Though the growth of S. aureus was 
inhibited, the carrier strain was still able to disturb the cytokines response of the nasal 
epithelial cells. After the infection of nasal epithelial cells with the nasal carrier strain of 
S. aureus, IL-1β levels in culture medium were lower than the respective cytokine levels 
from infection with noncarrier strains. The results of this study support the hypothesis 
of human cytokine-responsive bacteria. [294] Although S. aureus is most often found on 
nasal membranes and skin, the species occurrence in the subgingival microbiota has been 
reported. S. aureus strains can inhabit subgingival environments because approximately 
6% of the periodontal samples taken from 973 subgingival pockets contained this species 
[295]. It seems to be typical for nonsmoking patients with aggressive periodontitis, as 
this species was present in 60.5% of patients in the nonsmoking group [296]. 
TNF-α
In addition to IL-1β, two other pro-inflammatory cytokines, TNF-α and macrophage 
inflammatory protein-1α, are known to increase the growth of biofilm cultures. 
Interestingly, all cytokines may not have similar growth-promoting effects on the species 
because IL-6 has not shown any influence on biofilm growth [9]. Studies with Gram-
negative Shigella flexneri have revealed its ability to bind TNF-α and the virulence property 
alterations that occur after cytokine pretreatment. Based on experiments using [125I]-
labelled TNF-α, a single S. flexneri cell may contain nearly 300 proteinaceous receptors 
for TNF-α. As a physiological response, TNF-α pretreatment increases bacterial invasion 
of human cervical carcinoma (HeLa) cells 20-fold. It seems that cytokine binding to the 
bacterial cells is required for invasion. Treatment of HeLa cells with antibodies blocking 
TNF-α binding to the cells can also hinder the enhanced invasion of HeLa cells by 
TNF-α-treated S. flexneri. It was thus suggested that the cytokine-bacterium association 
may boost bacterial invasion of human cells. The binding of TNF-α is not a unique 
property of S. flexneri strains; Gram-negative Salmonella typhimurium and E. coli can 
also bind this cytokine, whereas Gram-positive Listeria monocytogenes, S. aureus and 
Streptococcus mitis bind considerably less TNF-α. [297]
Bacterial outer membrane receptors for cytokines
The publication of Zav’yalov et al. [10] was the first to describe the specific bacterial 
outer membrane receptor for IL-1β. The studies with Y. pestis, the etiologic agent of 
plague, showed that the outer membrane protein Caf1A specifically binds human IL-
1β [10]. The Caf1A protein is encoded by the f1 operon, which is responsible for the 
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synthesis and surface assembly of F1 capsule antigen (Caf1). The transportation of 
the capsule antigen through the outer membrane is dependent on the Caf1A protein 
[298,299]. The pore-forming Caf1A protein cooperates with periplasmic chaperones to 
assemble and secrete the polymeric F1 capsule (see review [300]). Sequence alignment 
demonstrated 28% homology between Caf1 antigen (aa 62-89) and human IL-Ra (aa 
57-85) [301]. Moreover, it is known that the Caf1 subunits possess an incomplete Ig-
like fold, and the periplasmic CafM chaperone displays Ig-like topology [302]. These 
incomplete Ig-like folds are typical both for proteins of the chaperone-usher pathway and 
for adhesins belonging to the MSCRAMM (microbial surface components recognising 
adhesive matrix molecule) family (see review [303]).
In Gram-negative P. aeruginosa, the outer membrane protein OprF was characterised 
as a specific binder of IFN-γ [8]. This species responded specifically to human IFN-γ 
because the cytokine caused an induction of P. aeruginosa lectin (PA-I or lecA) expression, 
which is known to be an important factor in the adherence of the species to endothelial 
cells [304]. The expression of LecA in P. aeruginosa as a result of IFN-γ binding to OprF 
was connected to QS signalling. Therefore, the deletion of genes playing major roles in 
QS signalling also caused the loss of lecA expression induction in P. aeruginosa after 
IFN-γ treatment [8]. Moreover, other tested human cytokines, including IL-2, IL-4, IL-6, 
IL-8, IL-10, IL-12 and TNF-α, did not have a similar type of effect on lectin expression 
[8]. Interestingly, none of the cytokines tested in the study had a growth promoting effect 
on P. aeruginosa [8], though another research group has shown the effect of IL-6 and 
TNF-α on species growth [288]. 
IL binding compounds in viruses and yeasts
In addition to bacterial species, herpesviruses and the pathogenic yeast C. albicans 
have been observed to disrupt host cytokine communication. Large DNA viruses, 
such as poxviruses and herpesviruses, have the ability to modulate the host immune 
system via the production of homologues to host cytokines, chemokines and their 
receptors (reviewed in [305]). In particular, herpesviruses such as herpes simplex virus, 
cytomegaloviruses and Epstein-Barr viruses [305] can all be isolated from periodontal 
lesions and subgingival plaques of patients with aggressive periodontitis [40,306]. 
Interestingly, Epstein-Barr virus encodes a BARF1 protein, which is a soluble ligand 
for human colony-stimulating factor-1 (CSF-1), and a recombinant BARF1 protein has 
been shown to antagonise the proliferative effect of human CSF-1 on mouse macrophage 
precursor cells [307]. Moreover, Epstein-Barr virus [308] and human cytomegalovirus 
[309] both encode a viral homologue of IL-10, which inhibits cytokine production 
in monocytes and macrophages (see review [310]). Vaccinia virus, a member of the 
poxvirus family, encodes a soluble receptor for IL-1β [311,312]. As these examples 
suggest, viruses have evolved specific mechanisms to modulate host immune responses 
to enhance their own survival.
C. albicans commonly occurs in subgingival samples of severe chronic periodontitis 
patients [39] and has been shown to bind high amounts of IL-2. It has been suggested 
that the cell wall oligomannosidic N-glycans are responsible for IL-2 binding [313,314]. 
Furthermore, pre-administration of soluble mannose causes a 60% reduction in IL-2 
binding to Candida cells [313]. This cytokine-carbohydrate interaction is rational, as 
the cytokines IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-6, IL-7 [315] and TNF-a [316] use their 
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carbohydrate-binding domains to recognise specific oligosaccharide ligands in humans 
(see review [317]). Moreover, IL-1α and IL-β demonstrate different carbohydrate binding 
activities [315] and different biological impacts, although they share the same target 
receptor IL-1R, which is expressed on nearly all cells (see review [25]). They both prefer 
to bind to anionic polysaccharides, but only IL-1β can interact with hyaluronic acid 
[318]. IL-1α binds N-glycan with two α-2-3-linked sialic acid residues, whereas IL-1β 
recognises the α-2-3-sialylated β-galactosyl-ceramides containing very long and unusual 
long-chain bases [319]. In addition to IL-2 binding, the biofilm formation of C. albicans 
was enhanced as a result of co-culture with peripheral blood mononuclear cells (PBMC). 
The supernatant of C. albicans biofilm-PBMC co-cultures contains high levels of IL-1β 
compared with supernatant derived from PBMC co-cultures infected with planktonic 
C. albicans. Moreover, this cytokine-rich supernatant from C. albicans biofilm-PBMC 
co-cultures induces C. albicans biofilm growth [320]. Based on these Candida studies, it 
appears that yeast biofilms can both bind and sense cytokines. If viruses and yeast have 
captured or evolved genes to specifically modulate human immune pathways, it can be 
assumed that bacteria have also evolved mechanisms to disrupt host immune processes 
during their long co-evolution with the human host.
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3. AIMS OF THE THESIS
The general aim of the thesis was to investigate whether the biofilms of an opportunistic 
oral pathogen Aggregatibacter actinomycetemcomitans can interact with the human 
inflammatory mediator IL-1β. A secondary aim was to examine the putative role of the 
outer membrane secretin protein HofQ in DNA uptake in A. actinomycetemcomitans 
biofilms. We hypothesised that A. actinomycetemcomitans might sense IL-1β and 
possess machinery for cytokine exploitation. Moreover, we hypothesised that the 
extramembranous portion of emHofQ is involved in DNA binding.
The specific objectives of the thesis were:
•	 To examine cytokine binding to biofilms and single cells of A. 
actinomycetemcomitans and to determine its effect on the biofilm properties.
•	 To find a putative bacterial outer membrane receptor for IL-1β and other proteins 
that interact with IL-1β in A. actinomycetemcomitans.
•	 To characterise DNA binding to the N-terminal portion of the A. 
actinomycetemcomitans outer membrane protein HofQ.
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4. MATERIALS AND METHODS
A more detailed description of the experimental procedures can be found in the original 
publications I-IV.
4.1.  A. actinomycetemcomitans strains (I, II, III)
Table 6 contains all of the A. actinomycetemcomitans strains used in this study. Most of the 
studies were performed with the clinical isolate D7S-1, which was isolated from an African-
American female patient with aggressive periodontitis [120]. The genomic sequence of this 
strain is known [23]. The WT A. actinomycetemcomitans D7S-1 strain and its derivatives, 
the naturally smooth colony variant D7SS [120] and a single gene mutants of the tad locus 
[321], were a gift from Prof. Casey Chen. The A. actinomycetemcomitans clinical strains 
SA1398 and SA1151 were from Prof. Sirkka Asikainen [321,322]. All gifted strains are 
described more detailed in paper I (I, Table I). The other clinical strains (RIB04, RIB07, 
and RIB09) were collected from adult periodontitis patients at the Community Dental 
Health Care Center of Turku (Institute of Dentistry, University of Turku, Turku, Finland). 
The isolation and identification of RIB strains were performed at the Helsinki University 
Hospital Laboratory (HUSLAB, Helsinki, Finland). Additionally, the serotypes of the 
threeRIB strains were analysed via PCR based serotyping [72,323] after chromosomal 
DNA isolation from A. actinomycetemcomitans cells [324,325]. 
Table 6. A. actinomycetemcomitans strains used in culturing experiments.
Strain Serotype Colony morphology Paper
D7S-1 a rough I, II, III
SA1398 b rough I, III
SA1151 c rough I, III
D7SS a smooth I
D7SΔflp1-flp2::Spe a smooth I
D7SΔrcpA::Spe a smooth I
D7SΔrcpB::Spe a smooth I
D7SΔtadD::Spe a smooth I
D7SΔtadG::Spe a smooth I
RIB04 b rough III
RIB07 c rough III
RIB09 a rough III
4.2.  A. actinomycetemcomitans biofilm cultures (I, II, III)
A. actinomycetemcomitans cells were stored at -80°C in milk. They were recovered by 
culturing on trypticase soy agar (TSA) plates supplemented with 5% defibrinated sheep 
blood in candle jars at 37°C for 2.5 to 3 days. Even cell suspensions were prepared 
by scraping the plate cultures into trypticase soy broth (TSB) supplemented with 0.6% 
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(weight/volume) yeast extract and 0.8% glucose (TSB-YE/Glc) according to the method 
described by Karched et al. [326]. In this method, an optical density (OD) of 1 at 600 
nm is equal to approximately 1 x 109 A. actinomycetemcomitans cells per ml. Bacterial 
culture was continued with the desired number of cells (0.5-5.0x107 cells) in TSB-YE/
Glc in 48-well tissue culture plates or in cell culture flasks for 18 h or 24 h. For gingival 
co-culture model studies, the biofilms were grown on hydrophilic polyethersulfone 
membranes (Protran® Whatman®) in the wells of cell culture plates, and these cultures 
were initiated with 1x107 bacteria per well. Biofilms formed at the bottom of cell plates 
were then rinsed twice with 0.85% NaCl solution to remove nonadherent bacteria. After 
washing, the culture medium was changed to RPMI-1640 medium (R7509, Sigma) 
supplemented with 4.1 mM L-glutamine (Sigma), and culturing was continued for 3, 
6, 18 or 24 h depending on the experiment. This minimal culture medium is suggested 
be optimal for bacterium-cytokine interaction studies, as it does not include complex 
organic materials that hinder the biological activities of cytokines [288].
4.3. Cloning, expression and purification of recombinant proteins in E. 
coli (I, II, III, IV)
Genomic DNA was isolated from A. actinomycetemcomitans D7S-1, RIB04, RIB07, 
RIB09 strains using the bacterial DNA extraction method developed by Moncla et al. 
[324]. Genomic DNA of the A. actinomycetemcomitans strain ATCC 700685 (HK1651) 
was commercially available from American Type Culture Collection (700685D-5). 
The genes encoding the A. actinomycetemcomitans F0F1 ATP synthase subunit 
beta (atpsynb), DNA binding protein HU (hu) and the extra-membranous part of 
HofQ (emHofQ; aa 27 to 195) were amplified from the genomic DNA of the A. 
actinomycetemcomitans strain HK1651. The genes encoding the type II/IV secretion 
system secretin RcpA (rcpA; aa 30-192) and the putative bacterial IL-1β receptor I (bilRI 
and cpbilRI; aa 19-181) were amplified from the A. actinomycetemcomitans strain D7S-
1. The residues 1-26 of emHofQ, 1-29 of RcpA and 1-18 of BilRI were excluded from 
cloning because the signal peptide prediction tool [327] suggested that they are secretion 
signals. However, the entire recombinant BilRI protein with the signal sequence was 
also produced in E. coli for flow cytometry and membrane fractionation studies. Phusion 
High-Fidelity DNA Polymerase (Finnzymes) was used in the PCR reactions to amplify 
the aforementioned DNA sequences. The cloning vectors pET-15b (Novagen) and 
pET-36b(+) (Novagen) were used for N-terminal 6xHis-tagged recombinant protein 
production and C-terminal 8xHis-tagged recombinant protein production, respectively. 
The constructs were prepared by digesting the amplified DNA fragments and suitable 
cloning vectors with NdeI/XhoI restriction enzymes (Fermentas) and then ligating the 
digested fragments with T4 ligase (Fermentas). Electroporation was used to transform 
the cloning vectors into E. coli XL1-Blue cells (Stratagene). Competent E. coli TOP10 
cells (Invitrogen) were used in the cloning of bilRI, and construction of the hu cloning 
vector included two separate digestion and ligation rounds. The PCR product of hu was 
first digested with XbaI/XhoI and ligated to the pBluescript (Stratagene) cloning vector 
digested with the same restriction enzymes. The hu-pBluescript construct and the pET-
36b(+) cloning vector were then digested with NdeI/XhoI prior to hu-insert ligation into 
pET-36b(+). Finally, the cloning vectors were sequenced in both directions by Eurofins 
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MWG Operon at the recombinant protein encoding regions to verify the sequences of the 
produced expression constructs. 
The sequenced cloning vectors were transformed into E. coli BL21-CodonPlus (DE3)-
RIL cells for cytosolic recombinant protein expression. The one exception was the signal 
sequence-containing bilRI gene in the pET-36b(+) vector, which was transformed into 
E. coli C41(DE3)-RIL cells. This C41 strain is designed for bacterial membrane protein 
overexpression [328]. Transformants containing a plasmid for cytoplasmic protein production 
were grown in Terrific broth medium supplemented with the proper antibiotics at 37°C. BilRI 
membrane protein (BilRI) expression was performed at 37°C in specific culture medium 
with a composition that is optimised for membrane protein expression in C41(DE3)-RIL 
cells [328,329]. The expression of soluble recombinant protein or membrane-associated 
BilRI was induced with isopropyl β-D-thiogalactopyranoside (IPTG) when an OD600nm of 
approximately 1.2 or 0.8 was reached, respectively. After 2 to 3 h of IPTG induction, BL21-
(DE3)-RIL cells were harvested and stored at -20°C. To avoid the lysis of recombinant 
C41(DE3)-RIL cells, these cells were stored in 50% glycerol at -20°C. Table 8 summarises 
the theoretical molecular weights and pIs of the produced recombinant proteins. 
E. coli cells were lysed using a French Press or ultrasound sonication. The crude extract 
was loaded onto a Ni2+-charged HisTrap™ HP column (Amersham Biosciences). After the 
immobilisation of His-tagged proteins, the target proteins were released with increasing 
concentrations of imidazole. Finally, the eluted protein fraction was further purified using 
a Superdex-200 16/60 size-exclusion chromatography column (GE Healthcare). The 
produced recombinant emHofQ protein used in crystallisation studies contained both a 
thrombin cleavage site and a His-tag in its N-terminus. emHofQ was released from the 
Ni-column using thrombin exposure, which caused the removal of the N-terminal His-tag. 
Additionally, a selenomethionine derivative form of emHofQ was used in crystallisation 
studies. This derivative of emHofQ was expressed using the Doublie method [330].











Size of the 
protein without 
His-tag (kDa)
pI of the protein 
without His-tag
atpsynb   pET-36b(+) NdeI/XhoI C-terminal 
8xHis
49.8*# 5.0


































* Extra amino acid residues due to C-terminal 8xHis-tag, LEHHHHHHHH, 1.4 kDa or due to 
N-terminal 6xHis-tag after thrombin treatment, GSHM, 0.4 kDa
# Computed extinction coefficient and A280 nm values used for protein concentration determination.
“ Protein concentration was measured using Lowry´s method for determining protein concentration [331].
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4.4. Characterisation of the effects of IL-1β on A. actinomycetemcomitans 
biofilms (I, II)
4.4.1. Biofilm mass estimation using crystal violet (I, II)
Biofilm colonies were grown on the bottom of 48-well cell culture plates as described 
above. Briefly, biofilm cultures were initiated by adding A. actinomycetemcomitans 
suspension containing 5x106 (I) or 5x107 cells (II) into each well. Even suspensions were 
prepared by harvesting the plate cultures into TSB-YE/Glc-medium. After culturing 
biofilms in a candle jar at 37°C for 18 h, the TSB-YE/Glc-medium was removed, and 
the biofilms were washed with sterile salt solution.
(I)  To examine the effect of IL-1β on biofilm mass formation, the biofilm culture was 
continued in RPMI-1640 medium with glutamine at 37°C for 6 h. In these studies, 
the medium was supplemented with recombinant human IL-1β (Reliatech GmbH) 
at a final concentration of 10.0 ng/ml. In control cultures, water was added instead 
of IL-1β.
(II)  The effects of the antibiotics penicillin and streptomycin on the biofilm mass of A. 
actinomycetemcomitans were studied. The biofilms were incubated in RPMI-medium 
for 24 h following 6 h or 25 h incubation in Green’s medium [332,333]. Green’s 
medium contains 65% DMEM (Life Technologies, Inc., Gibco®, cat#52100-039) 
supplemented with 0.17% NaHCO3 and 18 mM HEPES. In addition to DMEM, 
Green’s medium contains 25% Ham-F-12-medium (Life Technologies, Inc., 
Gibco®, cat#21765-029), 10% inactivated foetal bovine serum (Life Technologies, 
Inc., Gibco®), 4 mM L-glutamine (Life Technologies, Inc., Gibco®), 5 µg/ml insulin 
(Sigma), 0.4 µg/ml hydrocortisone (Sigma), 5 ng/ml epidermal growth factor (EGF) 
(Sigma), 0.1 nM cholera toxin (Sigma), 1.8 µg/ml adenine (Sigma) and 100 µg/ml 
ascorbic acid (Sigma). In half of the cultures, Green’s medium was supplemented 
with antibiotics (63.4 U/ml penicillin and 63.4 µg/ml streptomycin). 
After culture, the amount of biofilm formed at the bottom of wells was estimated 
using the crystal violet staining method described by Kaplan et al. [168]. Briefly, the 
biofilm was rinsed twice with water before adding the gram stain (20 mg/ml crystal 
violet, 8 mg/ml ammonium oxalate, 20% ml ethanol). The gram stain was incubated 
with the biofilm at room temperature (RT) for 10 minutes, followed by seven water 
washes to remove unbound stain. After washing, the crystal violet was released from the 
biofilm by adding 94% ethanol to the wells and incubating the culture plate with shaking 
at 100 rpm at RT for 10 minutes. Samples were taken from each culture well, and the 
A620nm was measured using a microplate reader.
4.4.2. Biofilm viability assay (II)
The effects of antibiotics on the viability of A. actinomycetemcomitans D7S-1 biofilm were 
determined by confocal microscopy and crystal violet staining methods [168]. Biofilms were 
grown in 48-well culture plates or on microscope cover glasses located in 6-well culture plates 
as described above. The cultures were initiated by pipetting an even bacterial suspension 
into each well (1.5x108 cells per well) and culturing the cells in TSB-YE/Glc for 24 h, 
followed by a subsequent 24-h incubation in RPMI-1640. After these incubations, biofilms 
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were incubated in Green’s medium for 6 h or 25 h. Half of the cultures was grown with a 
combination of penicillin (63.4 IU/ml) and streptomycin (63.4 µg/ml). After incubation, 
biofilms were gently rinsed with sterile water and then stained using a FilmTracer™ LIVE/
DEAD Biofilm Viability kit (Invitrogen) according to the manufacturer’s instructions. 
Imaging of the samples was performed in the Department of Biology and Cell Imaging 
Core, Åbo Akademi University (Turku, Finland). The samples were imaged by confocal 
laser scanning microscopy using a HCX PL APO 63x/1.20 W CORR water immersion 
objective on a Leica TCS SP5 confocal microscope. Images were analysed using LAS 
AF scanning software (Leica Microsystems CMS). Three sets of images were taken per 
specimen, and three independent biological replicates were prepared. The details of the scan 
settings for specimens and of the stacks scanned are described in paper II.
4.4.3. Metabolic activity of biofilm and planktonic cells (I)
The effect of IL-1β on the metabolic activity of biofilms was investigated using a 
commercial redox indicator, alamarBlueTM (AbD Serotec). Growing cells cause a chemical 
reduction of the indicator, which can be detected as a fluorescence change or as a colour 
change of the culture medium. For these metabolic activity studies, biofilm-forming rough 
strains were precultured as described above. In this experiment, 0.1 x107, 0.5 x107 or 2.5 
x107 cells were used to set up biofilm cultures on plates. After 18 h of preculture in TSB-
YE/Glc, biofilms were quickly rinsed with 0.85% NaCl solution, and the culture medium 
was changed to RPMI-1640 medium. Mature biofilms were then incubated either in the 
presence of recombinant human IL-1β (10 ng/ml) or in the presence of an identical volume 
of sterile water in the control cultures. AlamarBlueTM reagent was added as 10% of the 
sample volume at the same time as the cytokine or water in the control samples. At time 
points of 0, 0.5, 1, 1.5, 2, 3, 4, and 5 h after the addition of cytokine, the metabolic activity 
was measured by reading the fluorescence at 544 nm excitation and 590 nm emission. 
Biofilm culture was continued in candle jars at 37°C between measurements.
In the metabolic activity measurement of the smooth strains, bacteria were scraped 
off TSA-blood agar plates. Planktonic cultures (1x108 cells) were grown in TSB-YE/
Glc-medium in 14-ml polypropylene round bottom tubes (BD FalconTM #352006). After 
culturing the bacteria in candle jars at 37°C for 18 h, the cells were washed with 0.85% 
NaCl solution. The washed pellets were resuspended in RPMI medium, and 2.4x107 cells 
were transferred to the wells of a 48-well cell culture plate. Recombinant human IL-1β 
at a final concentration of 10 ng/ml was added; in control cultures, an equal volume of 
water was used instead of the cytokine. Finally, alamarBlueTM reagent was added to the 
cultures, and the fluorescence was measured as described above for the biofilm cultures.
4.5. Characterisation of IL-1β binding to A. actinomycetemcomitans 
biofilms and single cells (I, II, III)
4.5.1. Gingival mucosa co-culture (GMC) model (I, II)
Construction of the GMC model (I, II)
An organotypic GMC model (Fig 6) was used in this study to investigate the localisation 
of IL-1β in A. actinomycetemcomitans biofilms or inside a single bacterial cell. The 
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ability of the GMC model to produce IL-1β at moderate levels was ideal for the 
investigation of IL-1β localisation in biofilm cells. Additionally, gingival epithelium-A. 
actinomycetemcomitans biofilm interactions were examined using this model. The GMC 
model was modified from the F. nucleatum biofilm-oral mucosa model of Gursoy et al. 
[334]. 
Figure 6. Schematic presentation of the gingival mucosa co-culture (GMC) model. On the 
left is a simplified representation of the GMC model. The model consists of human gingival 
fibroblasts (HGF) cultured in a collagen gel, human gingival keratinocytes (HGK) seeded on 
the fibroblast-collagen matrix, and 2-day-old A. actinomycetemcomitans D7S biofilm in direct 
contact with the HGFs. The GMC model is grown at the gas-liquid interface. The spherical image 
of the biofilm at the top of the representation is gram stained only to visualise its appearance. The 
structure of the GMC can be observed in the haematoxylin and eosin-stained thin section on the 
right. Figure modified from the models of Oksanen and Hormia 2002 [333] and Gursoy et al. 
2010 [334].
A summary timetable of the GMC-A. actinomycetemcomitans biofilm model 
construction is represented in Table 8. Additionally, HGFs and HGKs were first grown 
according to standard cell culture methods in a humidified atmosphere of 95% air and 5% 
CO2 at 37°C before construction of the GMC model was initiated. HGFs were cultured 
in Dulbecco’s modified Eagle’s medium (DMEM, Life Technologies, Inc., Gibco®, 
cat#52100-039) supplemented with 10% foetal bovine serum (Life Technologies, Inc., 
Gibco®), recombinant epidermal growth factor (EGF, 5 ng/ml, Sigma), ascorbic acid 
(50 µg/ml, Sigma) and antibiotics (100 IU/ml penicillin and 100 µg/ ml streptomycin, 
EuroClone). HGKs originally obtained from a healthy human gingival biopsy sample 
[335] were cultured in keratinocyte-serum free medium (Life Technologies, Inc., Gibco®, 
cat#17005075) with bovine pituitary extract (50 µg/ml), recombinant epidermal growth 
factor (EGF, 5 ng/ml, Sigma), penicillin and streptomycin. HGFs (with passage numbers 
between 13 and 18) and HGKs (with passage numbers between 18 and 22) were passaged 
by incubation with 0.25% trypsin-EDTA (Life Technologies, Inc., Gibco®).
Model construction was initiated by suspending HGFs in collagen solution (PureCol®, 
Advanced BioMatrix) and allowing this suspension to solidify inside cell culture inserts 
(3 µm diameter, ThinCert™, Greiner Bio-One GmbH). The number of HGFs in each 
insert was 1.5x105. Two hours after casting the fibroblast-collagen gel, Green’s medium 
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[332] was added to the top of each insert, and culturing continued in the presence or 
absence of penicillin (63.4 IU/ml) and streptomycin (63.4 µg/ml). The composition of 
Green’s medium is described above (see chapter 4.4.1. Biofilm mass estimation).
The next day a keratinocyte layer was seeded above the solid fibroblast-collagen 
gel. Co-cultures were established with thin or thick HGK layers. A thin keratinocyte 
layer (1.50x105 HGKs per co-culture) was used for 8-h bacterial co-cultures, and a thick 
keratinocyte layer (4.0x105 HGKs per co-culture) was used for 24-h cultures. The thicker 
epithelium was used during longer incubations because the thin epithelium appeared 
too damaged to estimate epithelium thickness after elongated biofilm infections. One 
exception was made for the 24-h samples for immunoelectron microscopy specimens; in 
this case, a thin keratinocyte layer GMC sample was used. This longer culture time was 
chosen for technical reasons, and a thin keratinocyte layer was used because the basal 
IL-1β levels in the culture medium were higher with thin keratinocyte layers than with 
thick keratinocyte layers. On third day, the gingival co-culture inserts were lifted onto a 
metal grid, and mucosa model culturing was continued at the gas-liquid interface. The 
bottoms of the cell culture inserts were filled with cell culture medium. After growing 
organotypic gingival cultures on the grid for 5 days, 2-day-old A. actinomycetemcomitans 
D7S-1 biofilms grown on the membrane were placed above the HGK layer. After 8-h or 
24-h co-incubations, the culture media were harvested, and the co-cultures were fixed 
in 10% formalin solution overnight. The experiments were repeated at least three times. 
Table 8. Timetable for GMC model construction.
Day GMC Model Biofilm
1
HGFs suspended in collagen solution are 




HGKs are seeded on top of the collagen-
fibroblast matrix; 1.50x105 HGKs per 
thin culture and 4.0x105 HGKs per thick 
culture.
 
3 Cell inserts are lifted onto a metal grid and grown at the gas-liquid interface. Bacteria are plated on blood-agar plates.
4   
5 Culture medium change.  
6  Liquid phase biofilm cultures are initiated with 5.0x 107 bacteria per well. 
7 Culture medium change.
One-day-old biofilms formed on the 
membrane are washed, and culture medium 
is changed to minimal medium.
8/ 9 GMC model is infected with a 2-day-old biofilm in the presence or absence of antibiotics for 8 h or 24 h.
Culture medium analysis (II)
The culture media were collected from each GMC, and the total volumes of these media 
were quantified. Volume estimates were performed because the total volume of the 
medium in each well differed slightly due to varying heights of the metal grids. IL-
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1β production levels were determined for each GMC by measuring the amount of IL-
1β in the collected media samples using a commercial enzyme-linked immunosorbent 
assay (ELISA) (eBioscience) according to the manufacturer’s instructions. The IL-1β 
detection limit of this assay is 4 pg/ml. Our interassay variation was set at 100±20 pg 
with thin cultures at 0 h and at 40±15 pg with thick cultures. The IL-1β levels in the 
analysed culture media were ≥4 pg/ml.
Proportional lactate dehydrogenase (LDH) activities in the culture media of biofilm-
containing cultures were compared with the activities of filter-containing control 
cultures. LDH activities were measured using a Cytotoxicity Detection Kit PLUS 
(Roche Diagnostics) according to the manufacturer’s instructions. LDH activities were 
compared to determine if A. actinomycetemcomitans biofilms caused damage to the 
plasma membranes of human gingival cells. The amount of cells used (≥0.2-2x104) was 
high enough to meet the manufacturer´s requirements for sensitivity.
Gingival keratinocyte cell apoptosis, proliferation and appearance (II)
The apoptosis of HGKs was investigated in thin sections using a TACS® 2 TdT-DAB In 
Situ Apoptosis Detection Kit (Trevigen®) according to the manufacturer’s instructions. 
DNA fragmentation, which is characteristic of apoptosis, can be detected in permeable 
tissue sections by employing the terminal deoxytransferase (TdT) enzyme. This enzyme 
catalyses the integration of biotinylated nucleotides at the 3’ OH ends of DNA fragments. 
These biotin labelled fragments are then detected using streptavidin-horseradish 
peroxidase (HRP) and diaminobenzidine (DAB), the colorimetric substrate of HRP. 
Additionally, the proliferation of HGKs was examined in the thin sections of GMC. Cell 
proliferation can be studied by detecting Ki-67 expression in the cells by immunostaining. 
Proliferating cells express the Ki-67 protein during active phases of the cell cycle (G1, S, 
G2, and mitosis). In contrast, the absence of Ki-67 coincides with the resting phase of the 
cell cycle (G0). This immunostaining was performed as previously described by Gursoy 
et al. [334] using the TechMate (DAKO) automated immunostainer and a commercial 
kit (Universal LSAB™2 Kit/HRP, Rabbit/Mouse, DAKO, cat#KO675). Briefly, to detect 
the proliferation marker Ki-67, thin section samples were incubated with a monoclonal 
mouse anti-human Ki-67 antibody (DAKO), with biotinylated secondary linking 
antibody and with streptavidin-HRP (DAKO) in the abovementioned order. Finally, Ki-
67 expression in the tissue samples was visualised by DAB precipitation at the Ki-67 
sites, and the specimens were counterstained with haematoxylin. Ki-67-positive cells 
were counted in the stained sections prepared from 3 to 4 individual biological replicates. 
4.5.2. Immunostaining of GMC specimens (I, II)
The GMC samples were fixed in 10% formalin solution overnight, dehydrated using 
serial washes of increasing alcohol content (70%-100%) and embedded in paraffin wax. 
These samples were then cut into 4-µm-thick sections from paraffin blocks on poly-L-
lysine glass slides using a microtome. Xylene treatment was used to remove paraffin 
from the thin sections. The sections were rehydrated with a series of washes of decreasing 
ethanol content (99.6–70%) prior to rehydration in distilled water. Heat-induced epitope 
retrieval in the tissue sections was performed in citrate buffer (pH 6.0) in a microwave 
oven before the actual immunostaining protocol. 
48 Materials and Methods 
The commercial NovoLink™ Polymer Detection System kit (Novocastra Laboratories 
Ltd., cat# RE7290-K) was used to localise IL-1β in the biofilms. Immunostaining was 
performed according to the manufacturer’s instructions with the addition of proteinase 
K step after heat induction exposure to enhance epitope unmasking. After Proteinase 
K treatment, sections were incubated with rabbit anti-IL-1β antibody (NB600-633; 
Novus Biologicals) or with the negative control, rabbit immunoglobulin G (IgG, whole 
molecule; Jackson ImmunoResearch Laboratories) overnight. The next day, cytokine 
localisation was determined using the NovoLink polymer and the chromogenic substrate 
DAB. Finally, the slides were counterstained with haematoxylin and visually analysed 
to detect the brown precipitate at the antigen site. Additionally, an unconventional 
electron microscopy protocol [336] was employed with some immunostained specimens 
to achieve even greater magnification of DAB precipitate localisation in biofilm cells. 
In that protocol, the immunostained sections on glass slides were first fixed with 5% 
glutaraldehyde in 0.16 M s-collidine buffer, then incubated in 2% osmium tetroxide in 
water for 2 h. The sections were then dehydrated, embedded in epoxy resin and sectioned 
for electron microscopy. After resin removal, the sections were examined with a JEOL 
JEM-1200EX transmission electron microscope (Japan Electron Optics Laboratory).
4.5.3. Immunoelectron microscopy of GMC (II)
The GMC samples were first fixed in 4% paraformaldehyde supplemented with 2.5% 
sucrose. The next day, GMC samples were cut to smaller pieces using a biopsy punch and 
stored in 2.3 M sucrose in PBS. Subsequent steps of the immunostaining protocol were 
performed at the Biocenter Oulu (Department of Pathology, University of Oulu, Oulu, 
Finland) as follows. To obtain ultrathin sections for immunolabelling, the specimens were 
frozen in liquid nitrogen and cut with an ultramicrotome. To label the cryosections, they 
were first incubated in PBS + 0.2% gelatine, followed by incubation in PBS + 0.1% glycine. 
The blocked sections were incubated with a diluted primary rabbit anti-IL-1β antibody 
(NB600–633; Novus Biologicals) solution. Negative control samples were incubated in the 
absence of the primary antibody. The wash step was performed with PBS + 1% BSA before 
incubation in PBS supplemented with protein A–gold complex (size 10 nm) and 1% BSA 
for 30 min [337]. Finally, the sections were embedded in methylcellulose and examined 
using a Philips CM100 transmission electron microscope (FEI Company). Pictures were 
taken using a Morada CCD camera (Olympus Soft Imaging Solutions GMBH). 
4.5.4. Flow cytometry (I)
Flow cytometry was used to investigate whether A. actinomycetemcomitans cells are 
able to bind IL-1β. The study was performed using the Fluorokine® kit (R&D Systems).
All A. actinomycetemcomitans strains, both rough and smooth, were cultured on 
plates after which the cells were suspended in TSB-YE/Glc. Liquid cultures of biofilm-
forming strains (D7S, SA1398 and SA1151) were initiated by adding 5x108 cells to TSB-
YE/Glc in 50-ml tissue culture flasks (Cellstar #690160, Greiner Bio-One) and culturing 
the cells in candle jars at 37°C for 18 h. However, liquid cultures of the planktonic 
mutant and D7SS strains were initiated with a total of 1.0x109 cells. After overnight 
cultivation, flow cytometry experiments were performed. The biofilms were rinsed twice 
and the planktonic cultures were rinsed once with PBS buffer. Planktonic cells and the 
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detached biofilm cells were fixed with fixing-solution (1% paraformaldehyde, 1% BSA, 
0.01% EDTA in PBS) for 2 h at 4°C. Biofilm cells were then filtered through a 100-
µm Nylon Cell Strainer filter (BD FalconTM #2360) before adjusting the cell number 
of each sample to 1x108 cells. Cells were collected by centrifugation at 5,990 g for 
5 min, and the resulting pellets were suspended in 1 ml of sterile PBS. For labelling, 
2.5x106 A. actinomycetemcomitans cells were first treated with biotinylated IL-1β or 
with biotinylated control protein (soybean trypsin inhibitor, STI) for 1 h according to 
the instructions of the commercial Fluorokine® kit. According to the ProtParam tool 
[292], STI is 20.1-kDa protein with a pI of approximately 4.5, while IL-1β is a 17.4-
kDa protein with a pI of 5.9. After labelling with the biotinylated compounds, the cells 
were incubated with avidin conjugated to fluorescein isothiocyanate (FITC) for 30 
minutes. Unreacted avidin-FITC was removed using the 1x RDF1 buffer included in 
the kit. Samples diluted to a final volume of 1 ml in 1x RDF1 buffer were analysed 
with an Epics XL flow cytometer (Coulter Corporation). Forward scatter, side scatter 
(SSC) and FITC fluorescence at 525 nm were measured upon excitation with a 15-mV, 
488-nm argon ion laser. The signals were amplified with the logarithmic mode. Mean 
fluorescence intensity (MFI) and the percentage of fluorescence-positive bacterial cells 
were determined separately from approximately 5,000 bacteria per sample. 
4.6. Interaction of IL-1β with A. actinomycetemcomitans proteins (I, II, III)
4.6.1. Isolation of the membrane protein fraction from A. actinomycetemcomitans (I, III)
Two different protocols were used for the isolation of membrane proteins from A. 
actinomycetemcomitans. The first method [338,339] isolates outer membrane and inner 
membrane proteins into separate fractions (Fig 7). The soluble fraction containing the 
intracellular proteins of A. actinomycetemcomitans (Fig 7, designated as supernatant 
2) was used when the interaction of IL-1β with soluble cytoplasmic proteins of the 
A. actinomycetemcomitans D7S-1 strain was investigated (I, II). The outer membrane 
protein-containing fraction was used as a control sample when localisation of the 
identified total membrane protein was characterised (III).
The total membrane fraction was isolated as described by Paul-Satyseela et al. 
[339] but using a different buffer composition. A. actinomycetemcomitans cells were 
first scraped off culture plates into PBS (pH 7.4). After collection, the cells were 
suspended in PBS supplemented with 150 mM sucrose and 1 mM Pefabloc. Cells 
were lysed by sonication, and the cell debris was separated from the supernatant by 
centrifugation at 1,700 g. The supernatant was transferred to an ultracentrifuge bottle 
and underlaid with sucrose (0.9 M sucrose in PBS). The total membrane pellet was 
isolated using a 3-hour ultracentrifugation step at 150,000 g and stored at −20°C. 
After thawing, the membrane pellet was suspended in PBS supplemented with 4% 
CHAPS buffer (3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate) and 
1 mM phenylmethylsulfonyl fluoride (PMSF), and pellet dissolution was enhanced 
by incubating in a slowly rotating wheel at 37ºC. The undissolved components were 
collected by a brief spin, and the supernatant was used for electrophoretic mobility shift 
assay (EMSA) experiments. 
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4.6.2. EMSA of the intracellular protein fraction of A. actinomycetemcomitans (I, II)
The binding of IL-1β to intracellular proteins of the A. actinomycetemcomitans D7S-1 strain 
was examined by EMSA. Additionally, this method was later used to verify IL-1β interaction 
with the recombinant DNA binding protein HU to investigate A. actinomycetemcomitans 
nucleoid migration. The intracellular protein fractions were separated by a nondenaturing 
gel; samples were loaded in duplicate to yield two identical gel halves. One side of the 
gel was silver stained [340], and the second half was electroblotted onto a nitrocellulose 
membrane. The BSA-blocked membranes were incubated with biotinylated IL-1β or 
biotinylated control protein STI. After washing, the membranes were incubated with 
HRP-linked streptavidin (Sigma). Proteins interacting with biotinylated IL-1β on the blot 
produced a chemiluminescent signal after addition of the ECL Western blotting substrate 
(Pierce®, Thermo Scientific). The bands showing higher intensities with IL-1β than with 
STI were excised from the silver stained gel and identified by mass spectrometry (MS). 
This protein identification by MS was performed in the Turku Proteomics Facility (Turku 
Centre for Biotechnology, Turku, Finland). The MS protocol is described in paper I.
We used an EMSA method to study putative effects of IL-1β on the nucleoid binding 
of HU. Small nucleoid-associated proteins are known to impact chromosomal DNA 
structure, and we thus hypothesised that the interaction of IL-1β with HU could be 
observed as altered nucleoid migration. First, recombinant HU (60 pmol) was incubated 
with IL-1β (0.6 pmol and 6 pmol) or with similar amounts of STI in negative control 
samples. After this first incubation, nucleoids extracted from A. actinomycetemcomitans 
D7S-1 cells [341] were added to the reaction mix and incubation continued. After 
incubation, samples were loaded onto a 4–15% Tris–HCl native gel. The differences in 
protein migration were visualised by silver staining [340]. The ability of purified HU to 
bind to nucleoids and the presence of DNA contamination in the purified recombinant 
proteins were tested by running an agarose DNA gel and staining for DNA.
4.6.3. EMSA for the membrane protein fraction of A. actinomycetemcomitans (III)
The protein concentration of CHAPS-soluble membrane protein fraction was determined 
using the method described by Lowry et al. [331]. In an EMSA assay, the solubilised 
membrane protein fraction (2 µg) was incubated with 300 ng of recombinant IL-1β 
(Reliatech GmbH) or with equal volume of control buffer at RT for 1 h. Then, samples 
were loaded onto a nondenaturing 4-15% Tris-HCl gel. After electrophoresis the samples 
were visualised using silver staining [340] and western blotting analysis. In western 
blotting, the proteins were transferred onto a nitrocellulose membrane in a semi-dry 
blotter following the membrane blocking with PBS-skimmed milk solution. The IL-1β 
bands were visualised on nitrocellulose membrane with an Odyssey Infrared Imager (Li-
Cor) using rabbit anti-IL-1β antibody (NB600-633; Novus Biologicals) and fluorescently 
labelled secondary antibody [IRDye 800CW Donkey Anti-Rabbit IgG (H + L) Highly 
Cross Adsorbed (Li-Cor)]. A silver-stained membrane protein band that bound anti-IL-
1β was isolated from a gel and subjected to a mass spectrometry analysis. This analysis 
was performed in the Turku Proteomics Facility (Turku Centre for Biotechnology, Turku, 
Finland). Briefly, the sample was digested with trypsin prior to the resulting peptides were 
processed for coupled high-performance liquid chromatography/electrospray ionisation 
mass spectrometry/mass spectrometry (HPLC/ESI-MS/MS) analysis. The proteins 
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identified from MS analysis contained A. actinomycetemcomitans or human proteins 
because the protein hits from other species were filtered out. Additionally, protein hits of 
less than two peptides were also excluded during protein identification.
4.6.4. Microplate assay to study the interaction of IL-1β with recombinant A. 
actinomycetemcomitans proteins (I, II, III)
A microplate assay was used to verify the interaction between IL-1β and the recombinant 
proteins ATP synthase subunit β (ATPsynβ), HU and BilRI of A. actinomycetemcomitans. 
These three proteins showed interactions with IL-1β in previously described EMSA 
analyses. The N-terminal portion of the A. actinomycetemcomitans outer membrane 
protein RcpA (MW=19.3 kDa, aa 30-192) containing the same C-terminal 8xHis-tag 
as the tested recombinant proteins was used as a negative control in the ELISA studies. 
The detection method in this interaction study was based on the commercial HisProbe™ 
reagent (Thermo Scientific). The reagent was used according to the manufacturer’s 
instructions to detect the binding of the labelled probe to the C-terminal 8xHis-tag of 
recombinant proteins. In this protocol, the wells of a 96-well plate were first coated 
with similar amounts of BSA, IL-1β or STI negative control protein (Sigma). After the 
wells were coated, they were rinsed with wash buffer, and nonspecific binding sites 
in the wells were blocked with 1% BSA solution. Recombinant His-tagged proteins 
(Table 9) were then added to the wells and allowed to incubate overnight. The following 
day, the wells were carefully washed before incubation with wash buffer supplemented 
with HRP-conjugated HisProbeTM reagent. The interaction of recombinant His-tagged 
proteins with IL-1β was detected after adding HRP substrate ABTS (2,2’-Azinobis 
[3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt) solution and measuring the 
absorbance at 405 nm. The experiments were performed at least in triplicate.
Table 9. Protein concentrations (µM) used in the microplate assay investigating the interactions 
of recombinant proteins with human IL-1β.





ATPSynβ 0, 6 0, 3, 6, 12, 24, 48, 98 I
HU 0, 6 0, 28 II
cBilRI 0, 0.1 0, 100 III
RcpA (negative control protein) 0, 0.1or 0, 6 0, 3, 6, 12, 24, 48, 98 I, III
§IL-1β concentration used for well coating
*Recombinant 8xHis-tagged protein concentration in the coated well
4.6.5. Characterisation of the IL-1β interaction with BilRI (III) 
BilRI-recognising antibody fragments (III)
Selection and screening of BilRI-recognising antibody fragments and the production of active 
clones were performed by the MolBind Service (Department of Biochemistry, University of 
Turku, Turku, Finland). Briefly, two synthetic single-chain variable antibody fragment (scFv) 
phage libraries ScFvM [342] and ScFvP [343] were constructed. M13 phage display, cloning 
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of the scFvs into the screening vectors and expression of scFv-AP (AP, bacterial alkaline 
phosphatase) fusion proteins were performed as previously described [342,343]. The activity 
of BilRI-recognising antibody fragments was tested by a sandwich immunoassay, and ten 
active clones were identified, selected for further testing and produced as scFv-AP fusion 
proteins. The ability of the active clones to bind BilRI was also verified through western 
blotting, and clones 16B8 and 16F7 were selected for use in further analyses.
Bioinformatics (III)
The amino acid sequence of IL-1β-interacting membrane protein was analysed using the 
SignalP 4.1 server [327] to predict the presence and location of signal peptide cleavage 
sites. Additionally, the LipoP 1.0 server [344] was employed for the detection of the 
lipoprotein signal sequence. Subcellular localisation of the protein was estimated using the 
SosuiGramN tool [345]. Sequence similarity searches were performed with SIB using the 
BLAST network service. The SIB BLAST network service employs a server developed at 
SIB and NCBI BLAST 2 software [346]. Sequence alignments were performed using the 
ClustalW (1.83) program of the SIB T-Coffee multiple sequence alignment package [347]. 
Expression of BilRI in various clinical isolates of A. actinomycetemcomitans (III)
BilRI protein expression in six clinical A. actinomycetemcomitans strains was examined. 
In addition to the D7S-1, SA1398, and SA1151 strains that have shown IL-1β-binding 
capacity in our first studies (I), three other clinical strains RIB04, RIB07 and RIB09 
were tested. The strains were cultured as biofilms in cell culture flasks and initiated 
with 5x108 cells. The biofilms were first cultured in TSB-YE/Glc for approximately 18 
h and washed twice before culture was continued in minimal nutrient medium for 3 h. 
Cells were then detached using a cell scraper. Cells were suspended in Laemmli sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer at a 
final concentration of 450 mg/ml, which corresponded to approximately 9x109 CFU/ml. 
Cells were disrupted by sonication, and aliquots containing 0.3x107 disrupted cells were 
loaded onto a 10.5-14% Tris-HCl precast gel. Proteins were transferred to a nitrocellulose 
membrane. After blocking overnight with BSA, the membrane was incubated with an 
alkaline phosphatase-fused recombinant anti-BilRI antibody clone that was custom-
made using the M13 phage display as described above. The membrane was incubated 
with a biotinylated anti-alkaline phosphatase antibody (NB600-500; Novus Biologicals, 
Cambridge, UK), with HRP-labelled streptavidin (S2438, Sigma) and with the ECL 
substrate (Pierce®, Thermo Scientific); careful washes of the membrane with a Tween-
containing buffer were performed between each incubation step. BilRI expression by the 
clinical A. actinomycetemcomitans strains was detected by film.
Proteinase K treatment to examine the surface exposure of BilRI in A. 
actinomycetemcomitans (III)
Surface exposure of lipoprotein BilRI on intact cells was evaluated by Proteinase K 
treatment. A slightly modified version of a published Proteinase K treatment protocol 
was employed [348]. A. actinomycetemcomitans D7S-1 cells cultured on TSA plates 
were suspended in PBS and collected via centrifugation at 3,800 g for 10 minutes. The 
pellets were resuspended in PBS, and the suspensions were filtered through a 100-mm 
Nylon Cell Strainer (BD FalconTM #2360). Cell density was adjusted to 1.7x108 cells/
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ml with Proteinase K buffer (50 mM Tris-HCl, 5 mM CaCl2, 40 μg/ml chloramphenicol, 
pH 7.5) supplemented with 55 μg/ml globomycin (G1424, Sigma). The presence of 
chloramphenicol inhibited protein synthesis, and globomycin blocked the function of the 
lipoprotein-specific signal peptidase SPII [349,350] in bacteria. Globomycin treatment 
of cells was performed in Proteinase K buffer with shaking at 37ºC for 30 minutes, and 
the subsequent Proteinase K treatment was performed with 4.5x107 bacteria at a final 
Proteinase K concentration of 2 mg/ml. In the control samples, Proteinase K was replaced 
with an equal volume of sterile water. Proteolysis reactions were stopped after 0-, 5- or 
21-h incubations by the addition of 1 mM PMSF. The treated cells were harvested by 
centrifugation (3,800 g for 10 minutes) and washed once with Proteinase K-PMSF buffer. 
Finally, the resulting pellets were suspended in SDS-PAGE sample buffer and lysed via 
sonication (4x1 min, separated by 1 min incubation breaks on ice). Western blot analysis was 
performed similarly to the BilRI expression study described above. Proteinase K function 
was verified using outer membrane protein RcpA as a positive control in the proteolysis 
analysis. The immunostaining protocol of this control study contained a nitrocellulose 
membrane blocking with PBS-skim milk solution and an overnight incubation with 
custom-made rabbit polyclonal anti-RcpA antibody (0.8 μg/ml; Abcell). Additionally, the 
membrane was incubated with ECL™ Rabbit IgG, HRP-linked whole Ab (NA934, GE 
Healthcare) before HRP-substrate addition and film development. 
Membrane fraction isolation and flow cytometry of E. coli (III)
Recombinant E. coli C41(DE3)-RIL cells contained the complete BilRI sequence in a 
cloning vector. These cells expressed and secreted BilRI to the membranes after IPTG 
induction. Uninduced cells cultured in the absence of IPTG were used as controls for 
BilRI-expressing E. coli cells. Cell lysis during storage was examined to determine 
the optimal freezing conditions for membrane protein-overexpressing cells. The effect 
of glycerol on cell lysis was investigated by storing cells in different concentrations 
(20%-50%) of glycerol during freezing. Supernatant of the buffer-resuspended cells 
was collected after a freeze-thaw cycle by centrifugation at 16,000 g for 15 minutes. 
Supernatant samples were run in a 0.8% agarose gel containing Midori Green DNA 
Stain (Nippon Genetics Europe). Self-aggregation of the cells was also investigated. 
Cells were washed twice with HEPES buffer (10 mM HEPES, pH 7.4) after storage 
and suspended at cell density of OD600nm=1 in HEPES buffer supplemented with 50 mM 
CaCl2. After a 1-h incubation, self-aggregation of the cells was estimated visually.
Outer membrane (OM) fraction isolation from E. coli C41(DE3)-RIL cells containing 
the pET-36b-BilRI protein expression vector was performed using the protocol of 
Achtman et al. [351] with a slight modification. This method was utilised when the 
expression or localisation of BilRI in induced E. coli cells was investigated. Briefly, the 
induced cells stored in glycerol were washed twice with PBS before the pellets were 
suspended in 10 mM Tris (pH 8.0) supplemented with 0.2 mM PMSF. Cell numbers of 
each sample were adjusted to 2.5x109 using the cell number determination method of 
Volkmer and Heinemann [352]. According to this method, the concentration of E. coli 
cells cultured in Luria Bertani medium is 7.8±0.8x108 cells/ml when the OD600nm=1.0. 
After fine-tuning the number of cells, the cells were lysed by sonication, and cell debris 
from unbroken cells was then collected by centrifugation at 1,100 g for 20 minutes. OM 
fraction isolation continued by centrifuging the resulting supernatant samples at 48,000 
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g for 1 h. Pellets from the centrifugation were dissolved in water prior to OM extraction 
with Tris-buffer (11.1 mM, pH 7.6) supplemented with 1.67% sarkosyl. Insoluble outer 
membranes were collected with a 1.5-hour centrifugation at 48,000 g. Different cellular 
fractions (soluble cytosolic, sarkosyl-soluble inner and outer membranes) from the 
extraction were dissolved in 2% SDS. The silver staining method was used to visualise 
the presence of recombinant BilRI in SDS-dissolved samples. Using the dot blot method 
coupled to ECL (Pierce®, Thermo Life Science) detection, protein samples were 
observed on blotted nitrocellulose membrane. The absence of inner membrane-located 
heme proteins, which react with the ECL reagent, in the extracted outer membrane 
fraction was used as an indicator of OM fraction purity [353,354] in the dot blot method. 
Prior to the initiation of cell labelling for flow cytometry, E. coli cells were washed three 
times with PBS buffer to eliminate the glycerol storage solution. Cells were then fixed and 
labelled similarly to A. actinomycetemcomitans cells for flow cytometry. However, the 
number of E. coli cells was adjusted to 2.5x106 using the E. coli-specific cell concentration 
conversion [352]. Additionally, the avidin-FITC labelling step in the flow cytometry protocol 
was replaced with Syto9 (LIVE/DEAD ® BacLight™ Bacterial Viability and Counting Kit, 
L34856) green fluorescent nucleic acid staining for control E. coli samples. This staining 
enabled the determination of the actual proportion of bacteria in samples when a cytometric 
run was performed with the Beckman Coulter Cell Lab Quanta™SC Flow Cytometer 
(Beckman Coulter, Inc.). The FITC fluorescence of cells binding biotinylated antigen or 
Syto9-stained cells was measured at 525 nm after excitation at 488 nm with an argon ion 
laser. The percentage of fluorescence-positive bacterial cells and MFI were determined 
separately from approximately 10,000 bacteria per sample by gating the bacterial population 
according to the green fluorescence/SSC bivariate histogram. To exclude disturbing debris in 
the green fluorescence/SSC histogram, the discriminant was set to the SSC channel.
4.7. Characterisation of the extramembranous domains of HofQ (IV)
4.7.1. EMSA to examine protein-DNA interactions (IV)
Linearised pUC19-based plasmids were used to test the binding of emHofQ 
to double-stranded DNA in the EMSA assay. Additionally, the dependency of 
emHofQ DNA binding on USS was tested. Two separate plasmids were designed; 
plasmids with and without the USS were constructed as follows. A 760-nucleotide-
long region of the aggregation locus of the A. actinomycetemcomitans D7S-1 
genome (NC_017846.1, bases 1350204 to 1390964) was amplified by PCR. For 
USS plasmid construction, USS sequence (-5′-AAGTGCGGT, bold)-containing 
forward and reverse primers were used. The sequence of the forward primer was 
5-GCGACATATGAAGTGCGGTTTTTTTGTTTAAATCAGTTTCAGTGAGATA 
(NdeI site underlined), and the sequence of the reverse primer was 
5′-AGAAGGATCCAAGTGCGGTGTGTTTTTGTGGCGTTTTTA (BamHI site 
underlined). The constructed USS primer contained two USS sequences at both ends of 
the 760 bp insert. The following primers were used to construct a plasmid without the 
USS: forward primer, 5′-TTAACATATGCGGCGGTTTTTTGTTTAAATCAGTTTC
A; reverse primer, 5′-TATTGGATCCGTGMTGTTTTTGTGGCGTTTT). Primers 
for PCR were purchased from Eurofins MWG Synthesis GmbH, and Phusion High-
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Fidelity DNA Polymerase was used in the PCR. After PCR, reaction products and the 
pUC19 plasmid were a double digested with BamHI and NdeI. Restriction products 
were purified with the Qiaquick Gel Extraction kit prior to fragment ligation (T4 ligase; 
Fermentas) with the digested pUC19 plasmid and electroporated into competent E. coli 
XL1-Blue cells. Ampicillin (100 μg/ml) was used for transformant selection, which was 
followed by plasmid amplification and purification using the QIAprep Spin Miniprep 
kit (Qiagen). Plasmid constructs were verified by sequencing (Eurofins MWG Operon). 
The correct 0.76-kb USS insert-containing plasmid pUSS (Fig 8) was purified using 
the Qiagen Plasmid Midi Kit. After construct production, EMSA was performed by 
incubating the BamHI-linearised plasmids (300 ng) with emHofQ (100 μg), T4 gene 32 
protein (10 μg) (New England Biolabs) or BSA (100 μg) for 30 min at RT. Samples were 
loaded on a 0.8% agarose gel and visualised after the gel electrophoresis using GelRed 
DNA stain (Biotium) under ultraviolet light.
4.7.2. Crystallisation and structure determination (IV)
The crystallisation, data collection and structure determination were carried out by a 
collaborating group at Stockholm University (Sweden). Briefly, crystals were obtained 
by the sitting drop vapour diffusion method. Correct crystallisation conditions were 
determined using a Mosquito crystallisation robot (TTP Labtech) in the screening. 
Crystals formed in a 2 M sodium formate and 0.1 M sodium acetate (pH 4.6) well 
solution at 21°C after 5 days. Crystals were flash-cooled with liquid nitrogen using 25% 
glycerol as a cryoprotectant. The native data set was collected at beamline BM30, and 
multiwavelength anomalous diffraction data were collected at beamline ID14-1 at the 
European Synchrotron Radiation Facility (Grenoble, France). Detailed statistics of the 
data collection and structure refinement are reported in paper IV (IV: Table 1). 
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4.8. Ethics Statement (III)
The collection of subgingival plaque samples was approved by the Ethics committee 
of the Hospital District of Southwest Finland, Turku, Finland. Subgingival microbial 
samples from adult periodontitis patients were obtained with informed consent.
4.9. Statistics (I, II, III)
Significant differences were calculated using a Mann-Whitney U-test (I, crystal violet), 
the paired samples T-test (I, flow cytometry with tad locus deletion mutants), Student’s 
t-test (II and III) and Wilcoxon Signed Ranks Test (I, flow cytometry with clinical A. 
actinomycetemcomitans strains). Statistical significance was assigned at p<0.05 (I, II, 
III).
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5. RESULTS AND DISCUSSION
5.1. Effects of IL-1β on biofilm mass and A. actinomycetemcomitans 
metabolism (I, II)
Two tested clinical A. actinomycetemcomitans strains, D7S-1 (serotype a) and SA1151 
(serotype c), showed significantly (p<0.05) increased biofilm mass formation when 
biofilms were cultured in the presence of human recombinant IL-1β (10 ng/ml) for 6 h 
(I; Fig 1). Biofilm mass estimation was based on the crystal violet staining method [168]. 
The limitation of this study was that longer incubation times in the presence of IL-1β were 
not investigated. The incubation time was chosen for the technical reasons. Moreover, 
three-day-old A. actinomycetemcomitans biofilms are known to initiate dispersion [168], 
which restricted the monitoring of substantially older biofilms. 
In addition to the difference in total biofilm mass between the two groups, 
human IL-1β demonstrated a temporary impact on the metabolic activity of the A. 
actinomycetemcomitans D7S-1 biofilm (I: Fig 2A). IL-1β also decreased the metabolic 
activity of planktonic A. actinomycetemcomitans D7SS (I: Fig 2B), a spontaneous smooth 
colony mutant of the D7S-1 strain. The metabolic activity of A. actinomycetemcomitans 
was monitored by fluorescence detection after alamarBlue™ reagent reduction. IL-1β 
transiently decreased the metabolic activity of all three tested biofilm-forming clinical 
strains (D7S-1, SA1398 and SA1151). IL-1β caused a statistically significant decrease 
(p<0.05) in the metabolic activity of D7S-1 after 1 h of culture (I: Fig 2A). After 3 h of 
culture, the drop in metabolic activity was not significant (I: Fig 2A). Additionally, studies 
with the SA1398 and SA1151 biofilms suggested that the metabolic activity decrease is 
dependent on the IL-1β/cell ratio (data not shown). We thus hypothesise that the noted 
drop in metabolic activity was only transient, as biofilm cells may quickly consume the 
supplemented IL-1β. In the present study, the influence of repetitious IL-1β additions on 
the metabolic activity of the A. actinomycetemcomitans biofilm was not examined due to 
cytokine cost. To test our hypothesis, this type of study should be performed.
Additionally, we studied the putative role of the Tad secretion system in IL-1β uptake 
by using deletion mutants of the Tad system-encoding genes. This system is responsible 
for the assembly and export of fimbrial low-molecular-weight protein (Flp) and is 
encoded by 14 different genes (see review [157]). We examined the metabolic activity 
change in non-fimbriated Δflp1-flp2, ΔrcpA, ΔrcpB, ΔtadD and ΔtadG single gene 
mutant strains as a result of the IL-1β stimulus [321]. We observed that all mutants, with 
the exception of ΔrcpA, showed a transient metabolic activity decrease in the presence 
of IL-1β (I: Fig 2B). Furthermore, all non-fimbriated strains, including the ΔrcpA 
mutant, showed a similar weak fluorescence signal formation in the absence of cytokine. 
This result verifies that the basic metabolism of all mutants was similar; therefore, the 
observed difference between the ΔrcpA mutant and other non-fimbriated strains was 
not due to altered basic metabolism (I: Fig 2C). The ability to slow down metabolic 
processes and cell division usually makes bacteria more resistant to antibiotics and other 
antimicrobial agents (see review [355]). The tendency of A. actinomycetemcomitans 
biofilms to respond to the human inflammatory mediator IL-β by metabolic activity 
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decrease may be part of its pathogenic mechanism in periodontitis. To verify this putative 
connection, a study examining both the expression levels of RcpA in several clinical A. 
actinomycetemcomitans strains and their metabolic response to IL-1β is required. 
5.2. Viable A. actinomycetemcomitans biofilms bind and take up IL-1β (I, II)
The A. actinomycetemcomitans D7S-1 biofilms co-cultured with human gingival cells 
bound IL-1β produced by the GMC model (Fig 9), as the biofilms showed intense staining 
during immunolabelling. Labelling with the negative control antibody IgG did not stain 
the biofilms, suggesting that this staining with IL-1β was not due to nonspecific antibody 
binding. Moreover, the presence of antibiotics (penicillin and streptomycin) in the co-
culture medium prevented IL-1β binding to biofilms. (Fig 9) The ability of cell culture 
antibiotics to decrease the viability of A. actinomycetemcomitans D7S-1 biofilms was 
verified with LIVE/DEAD staining by confocal microscopy (II: Fig 1A). Additionally, the 
use of these antibiotics decreased the total A. actinomycetemcomitans biofilm mass when 
cultures were inspected with the crystal violet staining method (II: Fig 1B). The decrease 
in cell viability was observed after 6 h culturing, and the decrease was more obvious after 
25 h. In cell viability assays, the confocal microscope images were used for a qualitative 
analysis, and crystal violet staining was used for the quantification of biofilms. 
Figure 9. Viable A. actinomycetemcomitans biofilm binds IL-1β. After 8 h of co-culturing with 
organotypic gingival mucosa in the absence of antibiotics, two-day-old A. actinomycetemcomitans 
D7S-1 biofilms bound the IL-1β produced by the GMC model. Biofilms cultured with the 
GMC model containing antibiotics did not demonstrate IL-1β binding. The binding of IL-1β to 
biofilms was investigated using thin sections prepared from organotypic co-cultures. After the 
sections were treated with anti-IL-1β antibody or negative control IgG antibody, non-related IgG, 
immunostaining was completed using a commercial polymer detection method. B: biofilm; E: 
epithelial cell layer; CT: fibroblast-collagen matrix. Figure from Figure 2A (II).
Using an adapted transmission electron microscopy method, we demonstrated that A. 
actinomycetemcomitans D7S-1 biofilm cells co-cultured with the GMC model were able 
to take up IL-1β (I: Fig 3). A dark precipitate was localised to both sides of the double 
membrane and in the vicinity of bacterial nucleoids in anti-IL-1β stained specimens (I: 
Fig 3G). Additionally, positive control samples treated with the antibody against outer 
membrane protein RcpA showed intense precipitate formation (I: Fig 3H). In contrast, 
the control IgG-treated samples did not show these dark precipitates, excluding the 
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possibility of nonspecific antibody binding (I: Fig 3I). Immunoelectron microscopy was 
used to detect the precise location of IL-1β in co-culture specimens and to examine 
how antibiotics affect the IL-1β binding ability of bacterial cells (II: Fig 2C). The major 
findings of these experiments were that only viable A. actinomycetemcomitans biofilm 
cells could take up IL-1β (II: Fig 2C) and that intracellular IL-1β was often localised to 
the outer edges of nucleoids (II: Fig 3A). The localisation of IL-1β in specimens derived 
from antibiotic-free culture is described in Figure 10. Interestingly, specimens from 
GMC with A. actinomycetemcomitans biofilms grown in the presence of antibiotics did 
not show similar positive staining (II: Fig 2C). As expected, the keratinocyte cell layer 
of the GMC model was positively stained despite the use of antibiotics during culture 
(II: Fig 2C). However, the use of antibiotics appeared to have an effect on the appearance 
of biofilm cells. Single cells from biofilms cultured in the presence of antibiotics were 
smaller and more damaged according to immunostaining (II: Fig 2C). Furthermore, 
the LIVE/DEAD staining of biofilms integrated with the biofilm crystal violet staining 
described above confirmed that antibiotic treatment influenced the viability of A. 
actinomycetemcomitans biofilm cells (II: Fig 1).
Figure 10. Viable A. actinomycetemcomitans D7S-1 biofilm internalises IL-1β. IL-1β 
localisation in immunoelectromicroscopy specimens prepared from organotypic mucosa co-
cultures challenged with A. actinomycetemcomitans D7S-1 biofilm for 24 h without antibiotics. (A) 
Single biofilm cells contain IL-1β in the cytoplasm. (B) The magnification of a single cell shows 
that IL-1β is localised to the outer edges of nucleoids in some viable A. actinomycetemcomitans 
cells. (C) Based on positive staining, the epithelial cell layer produces IL-1β. Figure modified 
from Figures 2C and 3A (II).
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The detailed mechanism of the internalisation of IL-1β into A. actinomycetemcomitans 
cells remains unsolved. First, we should address the question of how it is possible for a 
bacterium to take up a compound as large as 17.4 kDa. A previous study by Kanagat et al. 
[7] showed that under >5 kDa peptide fragments of IL-1β, aa residues 118-147 or most 
importantly aa residues 208-240, had growth-promoting effects in S. aureus. In fact, the 
cytokine may be transferred through the membrane as a shorter fragment. Polyclonal 
IL-1β antibodies were used in our studies because they may produce more amplified 
signals at low IL-1β expression levels. Moreover, use of a monoclonal antibody results 
in a low risk of an unexposed epitope recognition site. The specific epitope recognition 
site of a monoclonal antibody might have been hidden by the interactions IL-1β of 
with A. actinomycetemcomitans-derived proteins and thus prevent IL-1β detection. 
Alternatively, the ability of the polyclonal antibody to interact with the entire IL-1β 
molecule or with a shorter peptide of the cytokine can be observed as a disadvantage of 
our immunoelectromicroscopy experiment. We cannot be sure whether the entire IL-1β 
molecule is taken up by the cells. It is known that macromolecules as large as 6 kDa can 
be passed through E. coli porins with molecular weight cut-off filters of 600 Da [356]. 
A follow-up study with A. actinomycetemcomitans biofilms cultured in the presence of 
specific IL-1β fragments might reveal the size of the cytokine that was taken up. The 
other important question that needs to be addressed is the quantification of IL-1β uptake. 
Our experiments did not show the exact amounts of IL-1β uptaken by the cell. The use 
of labelled [125I]-IL-1β [9] might produce more detailed information about the IL-1β 
sequestering and uptake capacity of A. actinomycetemcomitans biofilms.
The levels of IL-1β in the culture medium from GMC models with a thin 
keratinocyte layer were significantly higher (p<0.001) at 8 h of incubation with A. 
actinomycetemcomitans biofilm in the presence of antibiotics than in the absence of 
antibiotics according to ELISA analysis (II: Fig 2B). These findings reinforced our 
initial hypothesis about A. actinomycetemcomitans ability to uptake up IL-1β from its 
environment. However, this difference in IL-1β leakage in nonantibiotic and antibiotic-
treated A. actinomycetemcomitans co-cultures was not observed when the experiment 
was performed with thick keratinocyte layers and with 24 h of co-culture (II: Fig 2B). 
Therefore, the IL-1β production kinetics of our GMC model seems to be highly dependent 
on the thickness of the gingival cell layers and the duration of the bacterial challenge. 
Moreover, the complex interactions between the gingival cells and the bacterial biofilm 
hamper the understanding of IL-1β production kinetics even more. Furthermore, we have 
not determined the putative basal differences in the IL-1β production levels between 
HGKs and HGFs using monolayer cultures of these two tested GMC cell lines, and it 
is not known how each cell line impact on the other’s IL-1β production. The finding of 
lower IL-1β levels after 24-h bacterial challenge is in agreement with a study where HGFs 
stimulated with LPS from P. gingivalis produced significantly more IL-1β during the 
first 3 to 6 h than after 24 h of infection [220]. However, human gingival epithelial cells 
are known to steadily enhance their IL-1β production after the first 48 h of stimulation 
with soluble A. actinomycetemcomitans extract [357]. This result is in contrast with our 
finding that during an elongated challenge, IL-1β levels were considerably lower after 8 
h of exposure.
62 Results and Discussion 
5.3. IL-1β binds single A. actinomycetemcomitans cells (I, II, III)
Using flow cytometry, we demonstrated that biotinylated IL-1β binds whole A. 
actinomycetemcomitans cells (I: Fig 4). Cytokine binding was tested with three clinical 
strains (D7S-1, SA1398 and SA1151), the naturally smooth strain D7SS and the Tad 
system mutants (Δflp-1-Δflp2, ΔrcpA, ΔrcpB, ΔtadD, and ΔtadG). The Δflp1-flp2 
deletion mutant expressed all components of the Tad system apart from the fimbriae 
[321] required for nonspecific adherence and biofilm formation [55,158,160,321]. Four 
other mutants, ΔrcpA, ΔrcpB, ΔtadD and ΔtadG, could not form the functional channel 
for fimbria secretion and thus lost their nonspecific adherence ability [160,321,358]. 
RcpA forms an outer membrane secretin channel for fimbriae secretion [159]. Outer 
membrane protein RcpB is also required for bacterial adherence [358]. It has been 
hypothesised to play a role in assembly of the RcpA complex or to serve as a gate to 
the secretin pore [160]. The essential role of lipoprotein TadD in the outer membrane 
localisation of RcpA has been determined [159]. Moreover, the deletion of tadG is 
known to increase the fragility of single A. actinomycetemcomitans cells and stimulate 
the release of extracellular compounds from the bacterium [321]. TadG may also serve 
as a fimbriae anchor [321]. 
In our experiment, biotinylated IL-1β bound to all tested A. actinomycetemcomitans 
strains more efficiently than the negative control protein biotinylated STI (p<0.001). 
Therefore, IL-1β binding was not only a property of biofilm-forming isolates, as a 
relatively higher per cent of non-fimbriated Δflp1-flp2 mutant cells was positively stained 
compared with the three tested biofilm-forming strains (I: Fig 4A). This difference was 
statistically significant (p<0.05) only with strain SA1398 (I: Fig 4A). In contrast, all 
tested biofilm-forming strains showed higher mean fluorescence intensity per positive 
stained cell than the planktonic strains. However, a statistically significant (p<0.05) 
difference was observed only with SA1151 (I, Fig 4 B). 
In a flow cytometry study, IL-1β binding to whole cells was not significantly 
reduced (p<0.05) in any of the Tad system mutants (I: Fig 4A). This result indicates 
that none of the proteins (Flp, RcpA, RcpA, TadD or TadG) was a specific binder of 
IL-1β. However, two deletion mutant strains, ΔrcpA and ΔtadD, showed enhanced 
IL-1β binding compared with the control strain, a non-fimbriated Δflp1-flp2 mutant. 
Nevertheless, the difference in IL-1β binding was statistically significant (p<0.01) only 
with the ΔtadD mutant (I: Fig 4A). It is worth noting that a deficiency in one tad locus 
gene can affect the abundance, expression and stability of other proteins produced by 
the locus. For instance, the absence of TadD diminishes the localisation of RcpA and 
RcpB to the outer membrane [159]. Therefore, the enhanced IL-1β binding to a ΔtadD 
mutant cell might be explained by a coincidental deficiency in the outer membrane 
RcpA channel. We hypothesise that secretin RcpA forms a channel for IL-1β uptake 
and that cells can bind more IL-1β in the absence of the channel. The N-terminus of 
RcpA is hypothesised to form an immunoglobulin (Ig)-like fold found in structures 
such as IL-1RII (see reviews [157,359]). The outer membrane protein Caf1A from Y. 
pestis has been characterised as an IL-1β-binding bacterial receptor for the cytokine 
[10]. Caf1A of Y. pestis and RcpA of A. actinomycetemcomitans play in similar roles 
in F1 fimbrial capsule production and Flp1 fimbriae subunit assembly [157,298]. 
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However, based on our ELISA analysis, the N-terminal portion of recombinant RcpA 
(aa 30-192) did not bind to IL-1β (III; Fig 5C).
5.4. IL-1β interacts with the intracellular DNA-binding protein HU and 
ATP synthase subunit β 
The membrane and soluble protein fractions of the A. actinomycetemcomitans 
D7S-1 strain were extracted to further characterise the interaction of IL-1β with 
A. actinomycetemcomitans proteins. In an EMSA, an intracellular protein fraction 
contained two protein bands bound more effectively to biotinylated IL-1β than to the 
control protein, biotinylated STI, which has a similar size and charge to IL-1β (I: Fig 
3A-B; II: Fig 3B). These two protein bands were extracted from the silver stained 
native-PAGE gel (I: Fig 3C; II: Fig 5C) and identified by MS-based proteomic analysis. 
Seven peptides covering 14% of the sequence of ATP synthase subunit β (I: Fig 3D) 
and three peptides covering 77% of the sequence of DNA-binding protein HU (II: Fig 
3D) were identified. Both proteins are conserved among Gram-negative and Gram-
positive bacterial species. Intracellular IL-1β localisation (I: Fig 3G and II: Fig 3A) in 
proximity with the cytoplasmic side of the inner membrane and with the outer edges of 
nucleoids supports the putative interaction of IL-1β with ATP synthase subunit β and 
HU, respectively.
The interaction of these two identified intracellular proteins with IL-1β was verified 
by producing these two proteins in E. coli as recombinant proteins. In the case of ATP 
synthase subunit β, only the trimeric form of the recombinant ATP synthase subunit β 
bound IL-1β (I: Fig 6A–C), whereas the monomeric form of ATP synthase subunit β 
interacted only with the negative control protein STI (I: Fig 6D and E). Therefore, IL-1β 
seems to prefer the trimeric form of ATP synthase subunit β to its monomeric or dimeric 
form. Interestingly, ATP synthase subunit β is a central component of the ATP-producing 
F-ATPase, whose catalytic F1 sector contains three β subunits (see review [360]). 
Moreover, some cationic antimicrobial peptides between 10 to 50 residues in length 
have been suggested to inhibit the function of the E. coli ATP synthase by binding to its 
β subunit DELSEED-loop [361,362]. Our finding that the trimeric form of ATP synthase 
subunit β binds IL-1β might also explain the observed drop in metabolic activity after 
IL-1β treatment (I: Fig 2). 
Another A. actinomycetemcomitans intracellular protein that interacted with IL-
1β was DNA-binding protein HU (HU). HU is a homodimeric protein in the majority 
of Gram-negative bacteria, including A. actinomycetemcomitans [363], and it binds 
nonspecifically to DNA with a preference for A/T-rich DNA [364]. This protein is one of 
the factors responsible for bacterial DNA condensation and supercoiling [363,365]. It is 
known that changes in DNA packaging in E. coli have been linked to the alterations in 
the species gene expression profile [366]. Furthermore, HU regulates promoter activity 
by controlling the distribution of RNA polymerase in the nucleoid [367]. According to 
mutation studies, HU can regulate the expression of 8% of the E. coli genome [368]. In 
the oral pathogen P. gingivalis, the β subunit of HU regulates the expression of genes 
with roles in cell wall synthesis, cell division, iron uptake and capsule polysaccharide 
synthesis [369,370]. This putative interaction between HU and IL-1β could explain why 
IL-1β caused gene expression modulation in S. aureus [293]. By using an ELISA, we 
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determined that HU bound more efficiently (p<0.001) to IL-1β- than to BSA-coated 
wells (II: Fig 3E). However, HU also bound to STI-coated wells (II: Fig 3E), suggesting 
that the cationic HU interaction with IL-1β could be due to nonspecific electrostatic 
interactions. 
The ability of recombinant HU to interact with DNA and condense nucleoids 
was verified two different ways. First, the purified recombinant HU contained small 
amounts of DNA contamination as HU samples could be visualised in agarose gels 
stained for the presence of DNA (data not shown). Second, the preincubation of A. 
actinomycetemcomitans nucleoids with recombinant HU protein was required for 
nucleoid samples to migrate into a 0.5% agarose gel (data not shown). The amount 
of DNA-bound HU decreased in the native-PAGE EMSA gel if HU was allowed to 
first react with IL-1β and then with nucleoids (II: Fig 3F). This result indicates that the 
putative interaction between IL-1β and HU may disrupt the ability of HU to bind DNA. 
In contrast, preincubation with the control protein STI did not decrease the intensity of 
DNA-bound HU as much as IL-1β (II: Fig 3F). Therefore, the interaction of HU with IL-
1β and STI may not be the same. Furthermore, biotinylated IL-1β more efficiently bound 
to A. actinomycetemcomitans whole cells (I: Fig 4A) than biotinylated STI, suggesting 
that the internalisation of IL-1β is more likely than the internalisation of STI. The ability 
of biofilms to bind IL-1β might be partly explained by HU, as HU can also localise in 
the extracellular milieu of bacteria [126,371,372]. By combining our study results with 
what is known about HU extracellular location, we can hypothesise that extracellular 
HU may also sequester IL-1β. This IL-1β binding most likely causes some alterations to 
biofilm structure because HU acts together with IHF as critical maintenance factors in 
the structural integrity of the EPS matrix of biofilms [126,127]. However, further studies 
are required to confirm the specific role of IL-1β in the regulation of bacterial biofilm 
gene expression and metabolism through its interaction with HU and ATP synthase 
subunit β. In particular, quantification of bacterial IL-1β uptake must be determined. Our 
suggestions about the putative effects of IL-1β on the functions of two intracellularly 
abundant bacterial proteins requires that the internalisation of IL-1β or shorter IL-1β 
peptide fragments be efficient enough. For example, verification of the interaction 
between host-derived IL-1β and bacterial HU or ATP synthase subunit β could be 
performed using a proximity ligation assay in fixed GMC tissue samples.
5.5. IL-1β interacts with a membrane protein of A. 
actinomycetemcomitans
Because we knew that A. actinomycetemcomitans binds IL-1β, we wanted to investigate 
the interaction of the total membrane protein fraction with IL-1β to discover putative 
cytokine receptors from A. actinomycetemcomitans. In an EMSA analysis, the protein 
band in the blot that interacted with the anti-IL-1β antibody was only visible in 
lanes containing either IL-1β or the IL-1β-membrane protein (MP) combination (III: 
Fig 1A). However, the band intensity was the same in both samples (III: Fig 1A), 
indicating that both samples contained similar amounts of IL-1β. However, the most 
intense band in the silver-stained gel was present in the lane containing both IL-1β 
and MP (III: Fig 1B). Moreover, the band was not present in the lane containing only 
pure MP (III: Fig 1B). Furthermore, this phenomenon was not observed when IL-1β 
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was replaced with the control protein STI (III: Fig 1C), which has similar size and 
charge to IL-1β (STI: MW=20.1 kDa and pI=4.5; IL-1β MW=17,4 kDa and pI=5.9). 
Therefore, it was assumed that the intense band in the IL-1β-MP sample might contain 
proteins that interact with IL-1β. The intense protein band was identified by MS-
based analysis. The band contained IL-1β and one novel protein with no previously 
determined function. According to a BLAST search, the identified amino acid sequence 
covered approximately 75% of the protein sequence of a hypothetical protein from 
the A. actinomycetemcomitans D7S-1 strain (III: Fig 1D). We thus designated this 
A. actinomycetemcomitans protein as bacterial interleukin receptor I (BilRI). The 
bacterial outer membrane proteins Caf1A and OprF have been characterised as the 
cytokine receptors of Y. pestis and P. aeruginosa, respectively [8,10]. Caf1A forms 
a transmembrane channel in the outer membrane and is essential for F1 capsule 
formation, whereas OprF forms the porin channel for small polar compounds and also 
plays a role in the adhesion of P. aeruginosa to host cells (see reviews [300,373]). 
However, according to amino acid sequence homology searches, Caf1A demonstrates 
no sequence homology with BilRI or any other known A. actinomycetemcomitans 
proteins, and OmpA of A. actinomycetemcomitans shows only low sequence similarity 
with OprF. Lipoprotein Lpp, the major outer membrane protein of Gram-negative 
Enterobacteriaceae, has been characterised as a cell surface receptor that specifically 
recognises several cationic antimicrobial peptides [374].  
A BLAST search with BilRI showed close homology with several hypothetical 
proteins in the Pasteurellaceae family (III: Fig 2B and 3), but not in E. coli. The notable 
feature of BilRI and its homologous proteins was the number of charged residues. Thirty-
seven per cent of the mature BilRI peptide consisted of charged residues, including 37 
negatively charged and 23 positively charged residues. Furthermore, the amino acid 
sequence of A. actinomycetemcomitans BilRI contained 4 different 10-amino acid-long 
sequences (Fig 10 C; bold green, blue, purple and grey) repeated in the same order in 
triplicate. A similar type of repeats occurred also in other A. actinomycetemcomitans 
strains, Aggregatibacter aphrophilus strains (III: Fig 2B) and the Pasteurellaceae family 
(III: Fig 3). Conservation of the BilRI-encoding gene among Pasteurellaceae and its 
expression in clinical strains of A. actinomycetemcomitans suggest that BilRI may 
have an important function among this bacterial family. Unfortunately, we have not yet 
determined the significance of BilRI in A. actinomycetemcomitans. Characterisation of 
the A. actinomycetemcomitans ΔbilRI mutant might increase our understanding of the 
role of this protein. For example, our GMC model could be used for cytokine binding 
experiments, and the rat model for biofilm-mediated oral infection described by Freire 
et al., 2011 [375] would be ideal for determining whether BilRI affects the virulence 
of A. actinomycetemcomitans. Fibrinogen binder A (FgbA) of Haemophilus ducreyi is 
the only Pasteurellaceae protein with sequence similarity to have a known function. 
This lipoprotein contributes to the virulence of H. ducreyi and can bind to fibrinogen, 
suggesting a role in host-pathogen interactions [376]. Moreover, the ability of BilRI 
to interact with other host-derived compounds, such as fibrinogens, and with other 
proinflammatory mediators should be examined.
In a bioinformatic analysis, the N-terminus of the protein, including the first 
19 amino acids, showed typical features of a bacterial lipoprotein signal sequence 
[327,344]. A subcellular localisation tool [345] predicted that BilRI is targeted to 
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the outer membrane in Gram-negative species. Because the lipoprotein biosynthetic 
pathways in A. actinomycetemcomitans have received a little attention, we hypothesised 
that A. actinomycetemcomitans lipoprotein biosynthesis may show similarities to E. 
coli. The modification process of bacterial prelipoprotein is summarised in Figure 11 
(Fig 11 A and B). The D7S strain encodes and expresses homologues for the signal 
peptidase II (SPII, GI:387121531), lipid modification enzymes Lgt (GI:387120487) 
and Lnt (GI:387121253), and lipoprotein localisation machinery (Lol) of E. coli [377] 
according to BLASTP searches. The discovered homologies for the Lol apparatus in 
A. actinomycetemcomitans included LolA (GI:387121799), LolB (GI:387120279) 
and the inner membrane lipoprotein-releasing complex, LolCDE (GI:387122018; 
GI:387122019;GI:387122020). However, the amino acid sequence of BilRI contains 
two aspartate residues at the + 2 and +3 positions (Fig 11 C), which is a typical inner 
membrane signal known as the avoidance signal for the Lol system. Some lipoproteins 
containing this avoidance signal are still translocated to the outer surface of the OM, 
most likely through the Type II secretion pathway (see review [378]). Most all known 
lipoproteins in E. coli are assumed to be anchored to the outer membrane facing towards 
the periplasm [379,380]. However, at least one lipoprotein of E. coli, Wza, can form 
the integral outer membrane structures required for capsular polysaccharide export 
[381,382]. The Wza octamer arrangement inside the transmembrane region is an unusual 
barrel composed of amphipathic alpha helices [381,382]. The presence of lipoproteins in 
the outer leaflet of the outer membrane is more common in other Gram-negative species 
such as Neisseria meningitides, which has an incomplete Lol apparatus for lipoprotein 
transport [379]. 
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Figure 11. Biosynthesis of lipoproteins and the hypothesised biosynthetic pathway of BilRI. 
Briefly, lipoprotein precursors in the cytoplasm typically contain a signal sequence with a 
conserved sequence called a lipobox (A; yellow outline). Most lipoproteins in E. coli are 
exported from the cytoplasm by the Sec pathway (B). After prelipoprotein export, the first steps 
in the modification process are the attachment of a diacylglycerol group moiety to the cysteine 
residue by the diacylglyceryl transferase Lgt and the subsequent cleavage of the signal sequence 
by lipoprotein signal peptidase (SPII) (A). An additional fatty acid residue is then attached to 
the N-terminal cysteine residue by the N-acyltransferase Lnt prior to lipoprotein localisation 
machinery (Lol) export of the lipoprotein from the inner membrane to the outer membrane 
(A/B). Generally, the periplasmic chaperone LolA is required for the transport of hydrophobic 
lipoproteins through the hydrophilic periplasm to the outer membrane. Lipoprotein remains in the 
inner membrane of E. coli if it contains an avoidance signal adjacent to the conserved cysteine 
residue (A, red outlines) (see reviews [378-380]). Additionally, the 19-aa signal sequence of 
BilRI (C; bold red) contains a typical Sec signal peptide with a positively charged N-terminal 
region, a central hydrophobic H-region, and a polar C-terminal region with a peptidase cleavage 
site (see review [383]). In BilRI, the signal sequence is followed by several charged aa residues 
forming 4 direct tandem repeats of 10 aa (C; bold green, blue, purple and grey). Our hypothesised 
transport mechanism for BilRI suggests that the Lol system is not used for BilRI transportation 
(B). According to our experimental data, BilRI localises to the OM and is most likely faces 
external milieu. Moreover, BilRI exists as larger assemblies than monomeric units on the OM, 
implying that it might also form integral OM assemblies. Modified from Figure 2 of Okuda S. and 
Tokuda H. 2013 [380] and Figure 2A (III).
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The orientation of mature BilRI protein in the outer membrane of the A. 
actinomycetemcomitans D7S-1 strain was determined by Proteinase K treatment (III: 
Fig 6) and with two different antibody fragments against BilRI. Globomycin was used 
to specifically hinder the function of lipoprotein signal peptidase, and chloramphenicol 
prevented protein synthesis in A. actinomycetemcomitans. Therefore, the level of the 
19-kDa proprotein form remained constant throughout the experiment. As the Proteinase 
K treatment of whole cells resulted in the loss of intensity in the bands containing the 
largest assemblies of BilRI (III: Fig 6A and B), we suggest that some part of BilRI is 
surface exposed. Moreover, the outer membrane protein fraction of the D7S-1 strain 
contained two forms of BilRI with sizes of approximately 35 kDa and 70 kDa (III: Fig 
6A and B). The larger of the two forms was also found in the inner membrane protein 
fraction (III: Fig 6A). We hypothesised that the larger form was the immature BilRI 
assembly containing the lipidated side chain. The smaller assembly of approximately 
35 kDa existed only in the outer membrane protein fraction in large amounts (Fig 6A). 
Therefore, both of these forms are likely surface exposed in the outer membrane because 
their respective bands could be eliminated by Proteinase K treatment (III: Fig 6A and B). 
Interestingly, expression of the different forms of BilRI (the proprotein, the unlipidated 
mature form and the 70-kDa and 35-kDa forms) was observed in in vitro biofilm cultures 
of all tested clinical isolates of A. actinomycetemcomitans, which were obtained from 
periodontitis patients (III: Fig 6C). One potential technique to verify the localisation 
and amount of BilRI in single A. actinomycetemcomitans cells may be immunoelectron 
microscopy. The exact composition of these different protein forms of BilRI, including 
their oligomerisation and lipidation states, must be studied in more detail using MS-
based technologies. 
Overexpression of recombinant BilRI in E. coli resulted in less compact pellets after 
centrifugation (III: Fig 4C), visible cell aggregate formation in the presence of CaCl2 
(III: Fig 4F) and increased DNA leakage into the supernatant when bacterial pellets were 
exposed to a freeze/thaw cycle (III: Fig 4D). However, bacterial cell lysis was notably 
reduced when cells were frozen in 50% glycerol (III: Fig 4E). The increased fragility 
of E. coli cells was understandable, as the overproduction of outer membrane proteins 
generally results in enhanced membrane vulnerability in Gram-negative species [384]. 
Moreover, this result may imply that BilRI forms pore assemblies in the outer membrane 
similar to the Wza lipoproteins of E. coli [381,382]. The interaction between recombinant 
BilRI and IL-1β was verified using a microplate assay. It showed that BilRI binds to 
IL-1β (III: Fig 5C). The negative control protein from A. actinomycetemcomitans, the 
N-terminal portion of the outer membrane protein RcpA, did not bind to IL-1β (III: 
Fig 5C). However, BilRI bound almost identically to IL-1β and STI (III: Fig 5C). This 
result suggests that the purified soluble form of BilRI may differ structurally from the 
membrane-associated form of BilRI. Therefore, the interaction of BilRI with IL-1β 
was also examined with whole E. coli cells producing BilRI assemblies in their outer 
membranes. In the flow cytometry analysis, the detected ratio of positively stained E. 
coli cells was similar regardless of whether cells were overexpressing recombinant full-
length BilRI protein or not (III: Fig 5A). The putative ability of E. coli cells to bind IL-1β 
was predictable, as E. coli has been shown to specifically bind IL-1β [287]. However, 
significant binding of the control protein STI to E. coli cells was not observed (III: 
Fig 5A). Moreover, the finding that recombinant BilRI-producing E. coli cells showed 
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higher mean fluorescence intensity in positively stained cells than in control cells (III: 
Fig 5B) indicates more efficient IL-1β binding per cell in BilRI-expressing cells. Our 
findings indicate that the identified outer membrane lipoprotein BilRI interacts with 
human IL-1β.
5.6.  A. actinomycetemcomitans biofilm slightly affects HGKs
The GMC model was used as an in vitro tool to mimic conditions that an A. 
actinomycetemcomitans biofilm may encounter when in contact with subgingival dental 
tissue. Our model was based on Gursoy’s model [334], although we used gingival 
keratinocytes instead of skin keratinocytes. Moreover, different bacterial species and 
a different biofilm culturing technique were used. In our experiments, biofilms were 
pregrown in liquid phase and attached to a membrane. However, in the original model, 
agar plates were first inoculated with the bacterial suspension and then discs were placed 
on the agar plates to allow biofilm formation on the discs at the solid-gas interface. 
With these small modifications, our aim was to mimic the subgingival conditions where 
biofilms are surrounded by gingival crevicular fluid; however, our biofilms were not 
grown under the flow conditions that prevail in vivo.
Upon histological examination, the epithelium of the GMC model co-cultured with 
the A. actinomycetemcomitans D7S-1 strain often appeared damaged and thinned at sites 
of close contact with the biofilm (II: Fig 4A and 4C). This damaged appearance together 
with the well-known ability of the Cdt toxin produced by A. actinomycetemcomitans 
to cause apoptosis and necrosis in human cells (see review [95]) led us to examine 
whether the epithelium undergoes unregulated cell death, necrosis, or programmed 
cell death (apoptosis) when in contact with A. actinomycetemcomitans biofilm cells. 
Necrosis was investigated by analysing LDH activity in the cell culture medium. 
We assumed that cell damage in the co-cultured epithelium were not due to necrosis 
because the LDH activity was low after a 24-h incubation in the absence of antibiotics 
(data not shown). However, in our model the leakage of LDH from the epithelium 
into the culture medium might be limited by the collagen-fibroblast matrix. Moreover, 
Alaoui-El-Azher and co-authors have shown that human immortalised gingival 
keratinocyte monolayers release significant amounts of LDH 48-h after infection with 
A. actinomycetemcomitans [87]. 
The HGK proliferation decreased significantly in antibiotic-free medium after a 24-h 
incubation with a viable A. actinomycetemcomitans D7S-1 biofilm (II: Fig 4A and 4B). 
In the presence of antibiotics, the A. actinomycetemcomitans biofilm caused a slight, 
but not statistically significant, inhibition in HGK proliferation compared with the filter 
disc control after an 8-h incubation (II: Fig 4B) The stopping of the HGK proliferation 
during extended incubation with a viable A. actinomycetemcomitans biofilm may be 
caused by A. actinomycetemcomitans Cdt. This effective virulence factor expressed by 
A. actinomycetemcomitans causes apoptosis or cell-cycle arrest in several cell types, 
including T-cells, oral epithelial cells and fibroblast cells [84,86,95,385-387]. The free 
soluble filtrate extracted from A. actinomycetemcomitans D7S-1 biofilm cultures does 
not contain Cdt, but the species is known to secrete Cdt in outer membrane vesicles, 
which are delivered to target human cells [229,377,388]. It has been previously 
suggested that elongated (i.e., more than 24 to 48 h) exposure to the toxin is required 
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for the inhibition of human gingival epithelial cell proliferation [386]. However, in 
our study, decreased thickness and damage to the GMC epithelium was observed after 
24-h co-culture with a viable A. actinomycetemcomitans biofilm. Cdt might explain the 
damage and reduced epithelium thickness (II: Fig 4C) in GMCs challenged with viable 
A. actinomycetemcomitans biofilm for 24 h compared with the epithelium of filter disc 
control samples. This finding is consistent with another study in which human gingival 
tissue samples displayed separation of the keratinised surface layer at the junction of 
the oral epithelium as the result of an 18-h exposure to A. actinomycetemcomitans 
Cdt [93,94]. Unexpectedly, a slight inhibition in HGK proliferation was already 
observed after 8 h co-culture with A. actinomycetemcomitans (II: Fig 4B). The use 
of antibiotics may have damaged the A. actinomycetemcomitans cell structure and 
caused the unconventional release of Cdt from cells. However, this Cdt release from A. 
actinomycetemcomitans cells as the result of antibiotic treatment was not investigated. 
Moreover, A. actinomycetemcomitans may also sequester the IL-1β produced by gingival 
cells. This cytokine binding might interfere with complex cytokine signalling in the host. 
For instance, HeLa cells undergo apoptosis following IL-1β binding to IL-1R under low 
oxygen conditions [232]. Interestingly, the use of IL-1Ra inhibited cell death in the same 
experiment [232]. 
The apoptosis of epithelial cells challenged with A. actinomycetemcomitans D7S-1 
biofilm for 8 h increased slightly in the GMC model in the presence and absence of 
antibiotics (II: Fig 5). Sites that had close contact with the viable biofilm showed lower 
apoptosis levels during the 8-h incubation based on TUNEL staining for keratinocytes 
(II: Fig 5; open arrows), but a similar trend was not observed after a 24-h incubation 
(data not shown). These findings are in contrast with an earlier observation that 
human gingival epithelial cell multilayers show increased apoptosis 2 and 6 h after 
infection with an A. actinomycetemcomitans suspension [268]. However, there are 
several differences in these two models that may explain the contrasting results. In the 
model of Dickinson et al., 2011 [268], epithelial cells were cultured at the gas-liquid 
interface as in our model. However, our model contained a fibroblast layer below 
the epithelial cell layer. The presence of fibroblasts is known to influence epithelial 
cell growth and differentiation [389]. Therefore, the presence/absence of fibroblasts 
may result in differences in the apoptotic properties of epithelial cells. Moreover, we 
placed an A. actinomycetemcomitans D7S-1 biofilm precultured in minimal medium 
on top of the epithelial cell layer, whereas an A. actinomycetemcomitans VT1169 
suspension was used in Dickinson’s model. The virulence properties of the different 
strains or the use of biofilm culture instead of planktonic culture may also explain 
the observed difference in apoptosis. For example, the cytokine expression profile 
and apoptosis level of human keratinocyte cells exposed to S. aureus biofilms and 
planktonic cultures are different [390]. Additionally, the regulatory role of IL-1β in 
proliferation and apoptosis in certain human cell types has been stated [231,232,391]. 
Therefore, we cannot exclude the possibility that IL-1β binding by the viable biofilm 
might inhibit apoptosis at close range, which could partially explain the difference 
between the studies. Obviously, the significance of bacterial IL-1β binding must be 
studied in more detail.
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5.7. Extracellular domains of HofQ show DNA binding
The amino acid sequence of HofQ in competent A. actinomycetemcomitans D7S-
1 (GI:387120835) was compared with the sequences of ComE from H. influenzae 
(GI:59939227) and PilQ from N. meningitidis MC58 (GI:15678016) using a BLASTP 
algorithm. A. actinomycetemcomitans HofQ was observed to be approximately 70% 
identical over 448 amino acids to ComE and 30% identical over 407 amino acids to 
PilQ. As these homologues of HofQ have been described as outer membrane secretin 
pores associated with DNA uptake by neisserial species and H. influenzae [113,143], we 
assumed that the uncharacterised A. actinomycetemcomitans HofQ might play a similar 
role. Using EMSA, we showed that emHofQ (residues 27-195) could bind DNA (IV: Fig 
5). The T4 gene 32 protein (singe-stranded DNA binding) and BSA were used as negative 
controls. We also investigated the putative interaction of emHofQ with the 9-bp-long core 
USS, 5-AAGTGCGGT-3, as the DNA uptake machinery of A. actinomycetemcomitans 
is known to prefer DNA containing this sequence [120]. Linearised vectors either with or 
without the USS were used in the EMSA. DNA binding to emHofQ was not dependent 
on the presence of the core USS because emHofQ bound to both vector forms (IV: Fig 
5). This result was consistent with another study in which PilQ was shown to interact 
with DNA in a USS-independent manner [195].
The overall structure of crystallised HofQ was a dimer in the asymmetric unit (IV: 
Fig 1A). However, the particular crystallisation construct used may have caused the 
dimeric structure, and the oligomerisation state of the full-length protein could thus be 
different. Each emHofQ polypeptide chain contained two globular domains linked by a 
disordered segment of approximately 25 residues (IV: Fig 1C; broken lines indicate the 
disordered regions). Domain 1, which consists of residues 27-100 of emHofQ, showed 
little structural homology with any other known protein fold unless an alternative 
domain 1 was formed by means of a domain swap. After the domain swap, domain 1 and 
2 of emHofQ displayed both sequence and structural similarity (IV: Fig 3). Domain 2 is 
comprised of residues 127-191 of emHofQ and contains two α-helices flanked by a three-
stranded antiparallel β-sheet (IV: Fig 3 B and 3C). Domain 2 showed structural homology 
with the N-1 and N-2 domains of secretin peri-GspD from enteropathogenic E. coli (IV: 
Fig 4 A). It is worth noting that a putative DNA binding motif was identified in domain 
2 because this domain showed high structural similarity to the nucleotide-binding KH 
domain of Nova-1 (IV: Fig 4B). Most importantly, a conserved GxxG motif involved in 
nucleotide binding by KH domains (see review [392]) was also found in emHofQ. The 
GKGG motif of Nova-1 and the GGSG motif of domain 2 of emHofQ were found in a 
structurally similar location (IV: Fig 4B). KH domains are known to bind both RNA and 
DNA with low affinity [393,394]. In KH domains, the GxxG motif forms a protruding 
loop between two α-helices, while the GGSG motif of emHofQ protrudes from the axis 
of the preceding helix and is followed by an extended loop (IV: Fig 4B). Sequence 
alignment of the extramembranous region of A. actinomycetemcomitans HofQ with 
its homologues in six other Pasteurella species (A. pleuropneumoniae, H. ducreyi, H. 
influenzae, M. haemolytica, M. succiniciproducens and P. multicoda) demonstrates very 
high sequence similarity for domain 2 compared to domain 1, with strict conservation 
in many regions (IV: Fig 7). Therefore, domain 2 appears to be functionally involved in 
DNA uptake and competence; domain 1 may play more of a structural role and perhaps 
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be involved in gating. Interestingly, the unstructured region of HofQ between β-strands 4 
and 5 is not conserved in its sequence between these seven Pasteurella species. However, 
each of these seven homologues contained glycine-rich motifs that align with the GGSG 
motif in HofQ, with some also containing flanking or internal lysine residues (IV: Fig 7; 
displayed with a green outline).
5.8. Summary of results
•	 IL-1β bound both the A. actinomycetemcomitans D7S-1 biofilm and single cells 
of the three tested biofilm-forming A. actinomycetemcomitans strains (D7S-
1, SA1398 and SA1151). Additionally, single cells of four tad locus mutants 
in A. actinomycetemcomitans D7S-1 (ΔrcpA, ΔrcpB, ΔtadD and ΔtadG) and 
the naturally nonadherent A. actinomycetemcomitans D7S-1 strain (D7SS) 
demonstrated the ability to bind IL-1β. 
•	 A. actinomycetemcomitans biofilm culture in the presence of IL-1β resulted in 
elevated biofilm mass accumulation in three tested A. actinomycetemcomitans 
strains (D7S-1, SA1398 and SA1151). In contrast, the metabolic activity of these 
three A. actinomycetemcomitans strains transiently dropped in the presence of 
IL-1β. Furthermore, the ΔrcpA mutant of A. actinomycetemcomitans D7S-1 did 
not show a decrease in metabolic activity in the presence of IL-1β. Decreased 
metabolic activity was found in the three other tested tad locus mutants (ΔrcpB, 
ΔtadD and ΔtadG).
•	 The novel outer membrane lipoprotein of A. actinomycetemcomitans D7S-1 was 
designed as bacterial interleukin receptor I (BilRI) and was found to interact with 
IL-1β. This Pasteurellaceae-specific protein was expressed by biofilm cultures of 
all six tested A. actinomycetemcomitans strains, including D7S-1, SA1398 and 
SA1151. Similarly, the DNA binding protein HU and the trimeric form of ATP 
synthase subunit β, which are intracellular proteins of A. actinomycetemcomitans, 
were found to bind IL-1β.
•	 The extramembranous portion of A. actinomycetemcomitans outer membrane 
protein HofQ bound DNA in an USS-independent manner.
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6. CONCLUDING REMARKS AND FUTURE 
DIRECTIONS
During a long co-evolution with humans, micro-organisms have developed several 
ways to overcome the host immune response. Micro-organisms can avoid elimination 
by forming very tenacious biofilms in which single community members are 
surrounded by a protective extracellular matrix. Furthermore, some bacteria, yeast 
and virus species can even manipulate the signalling crosstalk of the immune system. 
For example, they can disrupt the host defence by expressing specific receptors 
against the key coordinating molecules of the innate immune system known as human 
proinflammatory mediators. Moreover, the ability of some biofilm-forming bacteria 
to modulate their own gene expression in response to human cytokines has been 
demonstrated. The purpose of this thesis was to study for the first time the ability of 
the Gram-negative oral pathogen, A. actinomycetemcomitans to sense IL-1β. In the 
side project, the putative role of the extramembraneous portion of the HofQ protein in 
DNA uptake was briefly investigated.
A. actinomycetemcomitans is often considered a central pathogen in the onset of 
aggressive periodontitis. Therefore, we hypothesised that this species may express 
machinery that senses the presence of IL-1β in the subgingival milieu. The selection 
of this species as the model organism for this study was supported by its ability to 
form biofilms and its previously annotated genome, which allowed the identification 
of IL-1β-interacting proteins in the bacterium. This study demonstrated that the 
IL-1β produced by gingival cells could enter the cytoplasm of the co-cultured A. 
actinomycetemcomitans biofilm cells. Previously, human cytokines had not been found 
inside a bacterium. The transient drop in metabolic activity in the biofilms and enhanced 
total biofilm mass after IL-1β exposure suggested that the species could also sense IL-
1β. The novel Pasteurellaceae-specific membrane protein, BilRI, and two conserved 
intracellular proteins, HU and ATP synthase subunit β, were characterised as IL-1β-
interacting components in A. actinomycetemcomitans. As our results also suggested 
that BilRI localises to the outer surface of the outer membrane, we hypothesise that 
BilRI is the first-line binder of IL-1β in A. actinomycetemcomitans. However, the 
putative function of these outer membrane BilRI assemblies as a channel for the uptake 
of IL-1β has yet to be verified. Moreover, a possible role for the outer membrane 
secretin RcpA in IL-1β transportation cannot be excluded, as deletion of the protein 
inhibited the metabolic activity drop in A. actinomycetemcomitans. Additionally, 
the IL-1β transportation mechanism through the periplasm and inner membrane is 
completely unknown. When the cytokine finally enters the cytoplasm, its interaction 
with the DNA binding protein HU and an energy production protein, the trimeric 
form of ATP synthase subunit β, might explain the observed changes in metabolic 
activity. The interaction of internalised IL-1β with HU could also explain the reported 
gene expression alterations in a different bacterial species after cytokine treatment. 
Our results indicated that sequestering of IL-1β by A. actinomycetemcomitans might 
slightly reduce human gingival epithelial cell proliferation. In the study with HofQ, 
it was noted that both the solved crystal structure and the DNA binding ability of 
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the extramembranous portion of HofQ supported its role in DNA acquisition in A. 
actinomycetemcomitans.
In this study, we have provided some new insights into an opportunistic periodontal 
pathogen’s ability to respond to the inflammatory micromilieu. We do not yet know 
the clinical significance of this phenomenon. In theory, it would be beneficial for the 
bacterium to be able to influence the timing and intensity of the host inflammatory 
response. The biofilm form of growth might be preferred after sensing high levels of 
key cytokines. In biofilms, single cells may evade the host defence because of their 
tolerance. Furthermore, biofilms might sequester host cytokines. As a result of this 
bacterial cytokine sensing, the host inflammatory response at the site of infection would 
de-escalate. After a more quiescent phase of infection, some bacteria would again 
disperse and begin a more active existence. Bacteria would then express their virulence 
factors and induce an active inflammatory response in the host. The destruction of host 
tissues would help nourish the biofilms with essential compounds such as iron. During 
the chronic inflammatory cycle, some dispersed pathogens would find more distant 
infection sites, while the some community members would remain at the original site 
and return to the quiescent phase. New follow-up studies have been initiated to gain 
a more comprehensive understanding of A. actinomycetemcomitans cytokine sensing. 
Whether A. actinomycetemcomitans can bind only IL-1β or whether it could also interact 
with other host cytokines and chemokines needs to be confirmed in further studies. After 
identification of the putative A. actinomycetemcomitans IL-1β receptor, we can test the 
significance of this receptor in IL-1β sequestering by preparing specific bilRI deletion 
mutants. Additionally, a study on the cytokine specificity of BilRI is being conducted. 
The purpose of our group is to solve the three-dimensional structure of BilRI. Although 
sequence homology for BilRI was found only in the Pasteurellaceae family, structure 
determination is essential to determine if other bacterial species express similar cytokine 
receptors to BilRI. 
This study demonstrated that IL-1β is an environmental signal for A. 
actinomycetemcomitans that is transferred through the membranes and into the cytoplasm 
where it interacts with its targets. It should be noted that the present study only investigated 
the ability of A. actinomycetemcomitans proteins to interact with IL-1β. We have not yet 
determined the strength of these discovered protein-protein interactions or the actual 
consequences of these interactions. Figure 12 summarises our current hypothesis about 
the mechanism by which A. actinomycetemcomitans senses IL-1β. This cytokine sensing 
may increase A. actinomycetemcomitans adaptation and subsequent persistence during 
chronic inflammatory conditions.
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Figure 12. Hypothesised model for the entry of IL-1β into the cytoplasm of A. 
actinomycetemcomitans. The extracellular host signalling molecule IL-1β is recognised by the 
outer membrane bacterial IL-1β receptor I (BilRI). We cannot exclude the possibility of an outer 
membrane pore formed by the oligomeric lipoprotein assemblies. Moreover, our result implies 
that the outer membrane secretin channel RcpA may be involved in cytokine uptake. However, 
the transfer mechanism of IL-1β from the outer membrane to the cytoplasm is still unknown, 
though we have shown that IL-1β is internalised by A. actinomycetemcomitans. Intracellular 
IL-1β may then affect the metabolic processes of the bacterium through its interaction with ATP 
synthase subunit β and with the DNA binding protein HU. Its interaction with HU might lead 
to the modulation of bacterial gene expression. OM=outer membrane, PG=peptidoglycan in 
periplasmic space, IM=inner membrane.
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